Pioneering API-Distribution since 1963
High-quality raw materials for safe, reliable pharmaceuticals
We at TIEFENBACHER API + INGREDIENTS offer an extensive portfolio of APIs + ingredients in all fourteen main ATC-Groups – in addition we have the permission to handle narcotics according to § 3 BtMG.
High quality raw materials are essential in the production of safe, reliable pharmaceuticals. We offer a comprehensive range of raw materials (Human + Veterinary) and controlled substances with the highest demand concerning quality and security. All our products are consistently manufactured to the highest quality standards at trusted GMP facilities in Europe and Asia. We cover both “super sales” molecules and niche molecules or specialized therapies. Tiefenbacher reduces supply chain vulnerability by having multiple sourcing options for safe, reliable pharmaceuticals.
Please find a selection of our raw materials (human & veterinary) with the highest demand concerning quality and security below. If you can’t find the API products (R&D and commercial) you’re looking for, please contact us by filling out the contact form below on this webpage, or please directly send an email to info-api@tiefenbacher.com.
| Product | CAS | ATC | Category | Dev Stage |
|---|---|---|---|---|
| 16-Alpha-Hydroxyprednisolone | 13951-70-7 | Human | Commercial | |
| 5-Fluorocytosine | 2022-85-7 | Human | Commercial | |
| 5-Fluoruracil | 51-21-8 | Human | Commercial | |
| Abacavir | 136470-78-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Abacavir Sulfate | 188062-50-2 | J Antiinfectives for Systemic Use | Human | Commercial |
| Abaloparatide | 247062-33-5 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Abaloparatide Acetate | n.a. | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Under Development |
| Abemaciclib | 1231929-97-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Abiraterone | 154229-19-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Abiraterone Acetate | 154229-18-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Abrocitinib | 1622902-68-4 | D Dermatologicals | Human | Under Development |
| Acalabrutinib | 1420477-60-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Acamprosate | 77337-76-9 | N Nervous System | Human | Under Development |
| Acamprosate Calcium | 77337-73-6 | N Nervous System | Human | Commercial |
| Acebutolol Hydrochloride | 34381-68-5 | C Cardiovascular System | Human | Commercial |
| Aceclofenac | 89796-99-6 | M Musculo-Skeletal System | Human | Commercial |
| Acetazolamide | 59-66-5 | S Sensory Organs | Human | Commercial |
| Acetyl-Carnitine Hydrochloride | 5080-50-2 | N Nervous System | Human | Commercial |
| Acetylchoune | 51-84-3 | Human | Commercial | |
| Acetylsalicylic Acid | 50-78-2 | Human | Commercial | |
| Aciclovir | 59277-89-3 | D Dermatologicals | Human | Commercial |
| Aciclovir Crystalline | n.a. | D Dermatologicals | Human | Commercial |
| Aciclovir Sodium | 69657-51-8 | D Dermatologicals | Human | Commercial |
| Acipimox | 51037-30-0 | C Cardiovascular System | Human | Commercial |
| Acitretin | 55079-83-9 | D Dermatologicals | Human | Commercial |
| Aclidinium Bromide | 320345-99-1 | Human | Commercial | |
| Aclometasone-17, 21-Dipropionate | 56348-65-7 | Human | Commercial | |
| Acrivastine | 87848-99-5 | R Respiratory System | Human | Commercial |
| Adagrasib | 2326521-71-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Adapalene | 106685-40-9 | D Dermatologicals | Human | Commercial |
| Adefovir Divopixil | 142340-99-6 | Human | Commercial | |
| Adenosine | 58-61-7 | C Cardiovascular System | Human | Commercial |
| Afatinib | 850140-72-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Afatinib Dimaleate | 850140-73-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Agomelatine | 138112-76-2 | N Nervous System | Human | Commercial |
| Agomelatine Cocrystal | n.a. | N Nervous System | Human | Commercial |
| Agomelatine Form I | n.a. | N Nervous System | Human | Commercial |
| Agomelatine Form II | n.a. | N Nervous System | Human | Under Development |
| Alcaftadine | 147084-10-4 | S Sensory Organs | Human | Commercial |
| Alclometasone Dipropionate | 67452-97-5 | D Dermatologicals | Human | Commercial |
| Alectinib | 1256580-46-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Alectinib Hydrochloride | 1256589-74-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Alendronate Sodium | 121268-17-5 | Human | Commercial | |
| Alfacalcidol | 41294-56-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Alfentanil Hydrochloride | 69049-06-5 | N Nervous System | Human | Commercial |
| Alfuzosin Hydrochloride | 81403-68-1 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Aliskerin | 173334-57-1 | Human | Commercial | |
| Alitretinoin | 5300-03-8 | D Dermatologicals | Human | Commercial |
| Alizapride Hydrochloride | 59338-93-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Allopurinol | 315-30-0 | M Musculo-Skeletal System | Human | Commercial |
| Allopurinol Isomorph | n.a. | M Musculo-Skeletal System | Human | Commercial |
| Alogliptin | 850649-61-5 | A Alimentary Tract and Metabolism | Human | Under Development |
| Alogliptin Benzoate | 850649-61-5 | A Alimentary Tract and Metabolism | Human | Under Development |
| Alogliptin Benzoate Form A | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Alpelisib | 1217486-61-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Alprazolam | 28981-97-7 | N Nervous System | Human | Commercial |
| Althiazide | 558-14-7 | Human | Commercial | |
| Alverine Citrate | 5560-59-8 | Human | Commercial | |
| Amantadine Hydrochloride | 665-66-7 | J Antiinfectives for Systemic Use | Human | Commercial |
| Amantadine Sulfate | 31377-23-8 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ambrisentan | 177036-94-1 | C Cardiovascular System | Human | Commercial |
| Ambroxol Hydrochloride | 23828-92-4 | R Respiratory System | Human | Commercial |
| Ambroxol Theophyllinate | n.a. | R Respiratory System | Human | Commercial |
| Amcinonide | 51022-69-6 | D Dermatologicals | Human | Commercial |
| Amifampridine | 54-96-6 | N Nervous System | Human | Under Development |
| Amifampridine Phosphate | 446254-47-3 | N Nervous System | Human | Commercial |
| Amifostine Trihydrate | 205923-56-4 | V Various | Human | Commercial |
| Amikacin Base | 37517-28-5 | D Dermatologicals | Human | Commercial |
| Amikacin Sulfate | 39831-55-5 | D Dermatologicals | Human | Commercial |
| Amikacin Sulfate 1.8 | n.a. | D Dermatologicals | Human | Commercial |
| Amikacin Sulfate 2.0 | n.a. | D Dermatologicals | Human | Commercial |
| Amiloride Hydrochloride Dihydrate | 2016-88-8 | C Cardiovascular System | Human | Commercial |
| Aminocaproic Acid | 60-32-2 | Human | Commercial | |
| Amiodarone | 1951-25-3 | C Cardiovascular System | Human | Commercial |
| Amiodarone Hydrochloride | 19774-82-4 | C Cardiovascular System | Human | Commercial |
| Amisulpride | 71675-85-9 | N Nervous System | Human | Commercial |
| Amitriptyline Hydrochloride | 549-18-8 | N Nervous System | Human | Commercial |
| Amlodipine | 88150-42-9 | C Cardiovascular System | Human | Commercial |
| Amlodipine Besylate | 111470-99-6 | C Cardiovascular System | Human | Commercial |
| Ammonium Lactate | 515-98-0 | Human | Commercial | |
| Amodiaquine Base | 86-42-0 | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Amodiaquine Hydrochloride | 6398-98-7 | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Amorolfine | 78613-35-1 | D Dermatologicals | Human | Commercial |
| Amorolfine Hydrochloride | 78613-38-4 | D Dermatologicals | Human | Commercial |
| Amoxapine | 14028-44-5 | N Nervous System | Human | Commercial |
| Amoxicillin Sodium | 34642-77-8 | J Antiinfectives for Systemic Use | Human | Commercial |
| Amoxicillin Trihydrate | 61336-70-7 | J Antiinfectives for Systemic Use | Human | Commercial |
| Amoxicillin Trihydrate and Potassium | n.a. | Human | Commercial | |
| Amphetamine | 300-62-9 | Human | Commercial | |
| Amphetamine Aspartate | n.a. | Human | Commercial | |
| Amphetamine Aspartrate H2O | n.a. | Human | Commercial | |
| Amphetamine Sulfate | 60-13-9 | Human | Commercial | |
| Amphotericin B | 1397-89-3 | Human | Commercial | |
| Amphotericin B Type II | n.a. | Human | Commercial | |
| Ampicillin and Sulbactam | n.a. | Human | Commercial | |
| Ampicillin Sodium | 69-52-3 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ampicillin Trihydrate | 7177-48-2 | J Antiinfectives for Systemic Use | Human | Commercial |
| Anagrelide Hydrochloride | 58579-51-4 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Anastrozole | 120511-73-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Anidulafungin | 166663-25-8 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ansofaxine Hydrochloride | n.a. | Human | Under Development | |
| Apabetalone | 1044870-39-4 | Human | Under Development | |
| Apalutamide | 956104-40-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Apixaban | 503612-47-3 | B Blood and Blood Forming Organs | Human | Commercial |
| Apixaban Amorphous | n.a. | B Blood and Blood Forming Organs | Human | Under Development |
| Apomorphine Hydrochloride | 41372-20-7 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Apraclonidine Hydrochloride | 73218-79-8 | S Sensory Organs | Human | Commercial |
| Apremilast | 608141-41-9 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Apremilast -B | n.a. | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Apremilast -M | n.a. | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Aprepitant | 170729-80-3 | Human | Commercial | |
| Apriprazol | n.a. | Human | Under Development | |
| Arformoterol Tartrate | 67346-49-0 | Human | Commercial | |
| Arformoterol Tartrate Polymorph A and D | n.a. | Human | Commercial | |
| Argatroban | 74863-84-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Argatroban H2O | 74863-84-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Aripiprazole | 129722-12-9 | N Nervous System | Human | Commercial |
| Aripiprazole H2O | n.a. | N Nervous System | Human | Commercial |
| Aripiprazole Lauroxil | 1259305-29-7 | N Nervous System | Human | Under Development |
| Armodafinil | 112111-43-0 | N Nervous System | Human | Commercial |
| Arsenic Trioxide | 1327-53-3 | Human | Commercial | |
| Arteether | 75887-54-6 | Human | Commercial | |
| Artemether | 71963-77-4 | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Artesunate | 88495-63-0 | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Articaine Hydrochloride | 23964-57-0 | N Nervous System | Human | Commercial |
| Asciminib | 1492952-76-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ascorbic Acid | 50-81-7 | Human | Commercial | |
| Asenapine Maleate | 85650-56-2 | Human | Commercial | |
| Atazanavir | 198904-31-3 | J Antiinfectives for Systemic Use | Human | Commercial |
| Atazanavir Sulfate | 229975-97-7 | J Antiinfectives for Systemic Use | Human | Commercial |
| Atenolol | 29122-68-7 | C Cardiovascular System | Human | Commercial |
| Atogepant | 1374248-81-3 | N Nervous System | Human | Under Development |
| Atomoxetine | 83015-26-3 | N Nervous System | Human | Commercial |
| Atomoxetine Hydrochloride | 82248-59-7 | N Nervous System | Human | Commercial |
| Atorvastatin | 134523-00-5 | C Cardiovascular System | Human | Commercial |
| Atorvastatin Calcium | 134523-03-8 | C Cardiovascular System | Human | Commercial |
| Atorvastatin Calcium Amorphous | n.a. | C Cardiovascular System | Human | Commercial |
| Atorvastatin Calcium Crystalline | n.a. | C Cardiovascular System | Human | Commercial |
| Atorvastatin Calcium Crystalline Trihydrate | 344423-98-9 | C Cardiovascular System | Human | Commercial |
| Atosiban Acetate | 90779-69-4 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Atovaquone | 95233-18-4 | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Atovaquone Form I | n.a. | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Atovaquone Form III | n.a. | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Atracurium Besylate | 64228-81-5 | M Musculo-Skeletal System | Human | Commercial |
| Atropine Base | 51-55-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Atropine Sulfate | 55-48-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Atropine Sulfate H20 | 5908-99-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Auranofin | 34031-32-8 | M Musculo-Skeletal System | Human | Commercial |
| Avanafil | 330784-47-9 | G Genito Urinary System and Sex Hormones | Human | Under Development |
| Avatrombopag | 570406-98-3 | B Blood and Blood Forming Organs | Human | Under Development |
| Avatrombopag Maleate | 677007-74-8 | B Blood and Blood Forming Organs | Human | Under Development |
| Avibactam Sodium | 1192491-61-4 | J Antiinfectives for Systemic Use | Human | Commercial |
| Axitinib | 319460-85-0 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Azacitidine | 320-67-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Azelaic Acid | 123-99-9 | Human | Commercial | |
| Azelastine Hydrochloride | 79307-93-0 | R Respiratory System | Human | Commercial |
| Azelnidipine | 123524-52-7 | Human | Commercial | |
| Azilsartan | 147403-03-0 | Human | Commercial | |
| Azilsartan Base | 863031-24-7 | Human | Under Development | |
| Azilsartan Kamedoxomil | 863031-21-4 | Human | Under Development | |
| Azilsartan Kamedoxomil Form I | n.a. | Human | Under Development | |
| Azilsartan Medoxomil Monopotassium | 149075-24-3 | Human | Under Development | |
| Azilsartan Medoxomil Potassium | 149075-24-3 | Human | Commercial | |
| Azithromycin Dihydrate | 117772-70-0 | J Antiinfectives for Systemic Use | Human | Commercial |
| Azithromycin H2O | 117772-70-0 | J Antiinfectives for Systemic Use | Human | Commercial |
| Aztreonam | 78110-38-0 | J Antiinfectives for Systemic Use | Human | Commercial |
| Baclofen | 1134-47-0 | M Musculo-Skeletal System | Human | Commercial |
| Balovaptan | 1228088-30-9 | Human | Under Development | |
| Baloxavir | 1985606-14-1 | Human | Under Development | |
| Baloxavir Marboxil | 1985606-14-1 | Human | Under Development | |
| Bamifylline Hydrochloride | 20684-06-4 | R Respiratory System | Human | Commercial |
| Bardoxolone Methyl | 218600-53-4 | Human | Under Development | |
| Baricitinib | 1187594-09-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Baricitinib Citrate | 1187595-84-1 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Barnidipine Hydrochloride | 104713-75-9 | C Cardiovascular System | Human | Commercial |
| Bazedoxifene | 198481-32-2 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Bazedoxifene Acetate | 198481-33-3 | G Genito Urinary System and Sex Hormones | Human | Under Development |
| Beclomethasone Dipropionate | 5534-09-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Beclomethasone Dipropionate H2O | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Beclomethasone-17, 21 Dipropionate | 5534-09-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Beclomethasone-17, 21 Dipropionate H2O | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Bedaquiline | 843663-66-1 | J Antiinfectives for Systemic Use | Human | Under Development |
| Bedaquiline Fumarate | 845533-86-0 | J Antiinfectives for Systemic Use | Human | Under Development |
| Belumosudil | 911417-87-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Belumosudil Mesilate | 1391787-60-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Bempedoic Acid | 738606-46-7 | Human | Under Development | |
| Benazepril Hydrochloride | 86541-74-4 | C Cardiovascular System | Human | Commercial |
| Bendamustine | 16506-27-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Bendamustine Hydrochloride | 3543-75-7 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Bendamustine Hydrochloride H2O | n.a. | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Bendroflumethiazide | 73-48-3 | C Cardiovascular System | Human | Commercial |
| Benfotiamine | 22457-89-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Benidipine Hydrochloride | 91599-74-5 | C Cardiovascular System | Human | Commercial |
| Benperidol | 2062-84-2 | N Nervous System | Human | Commercial |
| Benserazide | 322-35-0 | Human | Commercial | |
| Benserazide Hydrochloride | 14919-77-8 | Human | Commercial | |
| Benzbromarone | 3562-84-3 | M Musculo-Skeletal System | Human | Commercial |
| Benzhexol Hydrochloride | 52-49-3 | Human | Commercial | |
| Benzocaine | 94-09-7 | C Cardiovascular System | Human | Commercial |
| Benzododecinium Bromide | 7281-04-1 | D Dermatologicals | Human | Commercial |
| Benzphetamine Hydrochloride | 5411-22-3 | Human | Commercial | |
| Benztropine Mesilate | 132-17-2 | N Nervous System | Human | Commercial |
| Benzydamine Hydrochloride | 132-69-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Bepotastine Besylate | 190786-44-8 | Human | Commercial | |
| Bepridil Hydrochloride | 64706-54-3 | C Cardiovascular System | Human | Commercial |
| Berotralstat Hydrochloride | 1809010-48-9 | B Blood and Blood Forming Organs | Human | Under Development |
| Besifloxacin Hydrochloride | 141390-76-3 | S Sensory Organs | Human | Commercial |
| Betahistine Dihydrochloride | 5579-84-0 | N Nervous System | Human | Commercial |
| Betahistine Dimesilate | 5638-76-6 | N Nervous System | Human | Commercial |
| Betamethasone Acetate | 987-24-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Betamethasone Base | 378-44-9 | A Alimentary Tract and Metabolism | Human | Commercial |
| Betamethasone Benzoate | 2228-76-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Betamethasone Butyrate Propionate | 5534-12-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Betamethasone Dipropionate | 5593-20-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Betamethasone Valerate | 2152-44-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Betamethasone Valerate Acetate | 2152-44-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Betamethasone-21-Phosphate Disodium NaCl | 151-73-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Betamthasone Valerate | 2152-44-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Betaxolol Hydrochloride | 63659-19-8 | C Cardiovascular System | Human | Commercial |
| Betrixaban | 330942-05-7 | B Blood and Blood Forming Organs | Human | Under Development |
| Bexagliflozin | 1118567-05-7 | A Alimentary Tract and Metabolism | Human | Under Development |
| Bezafibrate | 41859-67-0 | C Cardiovascular System | Human | Commercial |
| Bicalutamide | 90357-06-5 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Bicalutamide Form I | 90357-06-5 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Bictegravir | 1611493-60-7 | J Antiinfectives for Systemic Use | Human | Under Development |
| Bictegravir Sodium | 1611493-60-7 | J Antiinfectives for Systemic Use | Human | Under Development |
| Bifonazole | 60628-96-8 | D Dermatologicals | Human | Commercial |
| Bilastine | 202189-78-4 | R Respiratory System | Human | Commercial |
| Bilastine Form I | 202189-78-4 | R Respiratory System | Human | Under Development |
| Bilastine Form II | 202189-78-4 | R Respiratory System | Human | Commercial |
| Bimatoprost | 155206-00-1 | S Sensory Organs | Human | Commercial |
| Binimetinib | 606143-89-9 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Biperiden Base | 514-65-8 | N Nervous System | Human | Commercial |
| Biperiden Hydrochloride | 1235-82-1 | N Nervous System | Human | Commercial |
| Birone | n.a. | Human | Under Development | |
| Birone Hydrochloride | n.a. | Human | Commercial | |
| Bisacodyl | 603-50-9 | A Alimentary Tract and Metabolism | Human | Commercial |
| Bisoprolol | 66722-44-9 | C Cardiovascular System | Human | Under Development |
| Bisoprolol Fumarate | 104344-23-2 | C Cardiovascular System | Human | Commercial |
| Bivalirudin | 128270-60-0 | B Blood and Blood Forming Organs | Human | Commercial |
| Bleomycin Sulfate | 9041-93-4 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Blonanserin | 132810-10-7 | Human | Under Development | |
| Bortezomib | 179324-69-7 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Bosentan | 147536-97-8 | C Cardiovascular System | Human | Commercial |
| Bosentan H2O | n.a. | C Cardiovascular System | Human | Commercial |
| Bosutinib | 380843-75-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Bosutinib Form l | 380843-75-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Bosutinib H2O | n.a. | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Bremelanotide | 189691-06-3 | G Genito Urinary System and Sex Hormones | Human | Under Development |
| Brexanolone | 516-54-1 | N Nervous System | Human | Commercial |
| Brexpiprazole | 913611-97-9 | N Nervous System | Human | Under Development |
| Brexpiprazole Anhydrous | 913611-97-9 | N Nervous System | Human | Under Development |
| Brigatinib | 1197953-54-0 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Brimonidine | 59803-98-4 | D Dermatologicals | Human | Under Development |
| Brimonidine Tartrate | 70359-46-5 | D Dermatologicals | Human | Commercial |
| Brinzolamide | 138890-62-7 | S Sensory Organs | Human | Commercial |
| Brivaracetam | 357336-20-0 | N Nervous System | Human | Commercial |
| Bromazepam | 1812-30-2 | N Nervous System | Human | Commercial |
| Bromfenac Sodium | 91714-94-2 | S Sensory Organs | Human | Commercial |
| Bromfenac Sodium 1.5H2O | n.a. | S Sensory Organs | Human | Commercial |
| Bromocriptine Mesilate | 22260-51-1 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Bromopride | 4093-35-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Brotizolam | 57801-81-7 | N Nervous System | Human | Commercial |
| Bucillamine | 65002-17-7 | M Musculo-Skeletal System | Human | Commercial |
| Budesonide | 51333-22-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Bufexamac | 2438-72-4 | D Dermatologicals | Human | Commercial |
| Bumetanide | 28395-03-1 | Human | Commercial | |
| Bupivacaine | 38396-39-3 | N Nervous System | Human | Commercial |
| Bupivacaine Hydrochloride | 18010-40-7 | N Nervous System | Human | Commercial |
| Buprenorphine Base | 53152-21-9 | N Nervous System | Human | Commercial |
| Buprenorphine Hydrochloride | 53152-21-9 | N Nervous System | Human | Commercial |
| Bupropion | 34911-55-2 | N Nervous System | Human | Commercial |
| Bupropion Hydrobromide | 374318-05-5 | N Nervous System | Human | Under Development |
| Bupropion Hydrochloride | 31677-93-7 | N Nervous System | Human | Commercial |
| Buserelin Acetate | 57982-77-1 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Busulfan | 55-98-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Butamirate Citrate | 437-38-7 | Human | Commercial | |
| Butenafine Hydrochloride | 101827-46-7 | D Dermatologicals | Human | Commercial |
| Butizide | 2043-38-1 | Human | Commercial | |
| Butoconazole Nitrate | 64872-77-1 | Human | Commercial | |
| Butorphanol Tartrate | 58786-99-5 | Human | Commercial | |
| Cabazitaxel | 183133-96-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Cabergoline | 81409-90-7 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Cabotegravir | 1051375-10-0 | J Antiinfectives for Systemic Use | Human | Under Development |
| Cabotegravir Base | 1051375-13-2 | J Antiinfectives for Systemic Use | Human | Under Development |
| Cabotegravir Sodium | n.a. | J Antiinfectives for Systemic Use | Human | Under Development |
| Cabozantinib | 849217-68-1 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Cabozantinib Malate | 1140909-48-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Cabozantinib S-Malate | 849217-68-1 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Calcifediol | 19356-17-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Calcipotriene | 112828-00-9 | Human | Commercial | |
| Calcitonin Salmon Acetate | 47931-85-1 | Human | Commercial | |
| Calcitriol | 32222-06-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Calcium | 7440-70-2 | Human | Commercial | |
| Calcium Dobesilate H2O | 69957-16-8 | Human | Commercial | |
| Calcium Gluconate | 299-28-5 | Human | Commercial | |
| Calcium Oxybate | n.a. | Human | Commercial | |
| Camostat | 59721-28-7 | B Blood and Blood Forming Organs | Human | Commercial |
| Camostat Mesilate | 59721-29-8 | B Blood and Blood Forming Organs | Human | Commercial |
| Camphor | 76-22-2 | Human | Commercial | |
| Camylofin Dihydrochloride | 15787-33-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Canagliflozin | 842133-18-0 | A Alimentary Tract and Metabolism | Human | Under Development |
| Canagliflozin Hemihydrate | 928672-86-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Candesartan | 139481-59-7 | C Cardiovascular System | Human | Commercial |
| Candesartan Cilexetil | 145040-37-5 | C Cardiovascular System | Human | Commercial |
| Cangrelor Tetrasodium | 163706-36-3 | Human | Under Development | |
| Cannabidiol | 13956-29-1 | N Nervous System | Human | Commercial |
| Cantharidin | 56-25-7 | Human | Under Development | |
| Capecitabine | 154361-50-9 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Capmatinib | 1029712-80-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Captopril | 62571-86-2 | C Cardiovascular System | Human | Commercial |
| Carbamazepine | 298-46-4 | N Nervous System | Human | Commercial |
| Carbetocin Acetate | 37025-55-1 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Carbidopa | 28860-95-9 | Human | Commercial | |
| Carbimazole | 22232-54-8 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Carbocysteine | 638-23-3 | R Respiratory System | Human | Commercial |
| Carbocysteine Lysine NaCl | n.a. | R Respiratory System | Human | Commercial |
| Carboplatin | 41575-94-4 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Carfilzomib | 868540-17-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Carglumic Acid | 1188-38-1 | Human | Under Development | |
| Cariprazine | 839712-12-8 | N Nervous System | Human | Under Development |
| Carisoprodol | 78-44-4 | M Musculo-Skeletal System | Human | Commercial |
| Carmustine | 154-93-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Carperitide | 89213-87-6 | Human | Commercial | |
| Carvedilol | 72956-09-3 | C Cardiovascular System | Human | Commercial |
| Carvedilol Phosphate | 103277-45-8 | C Cardiovascular System | Human | Commercial |
| Caspofungin | 162808-62-0 | J Antiinfectives for Systemic Use | Human | Under Development |
| Caspofungin Acetate | 179463-17-3 | J Antiinfectives for Systemic Use | Human | Commercial |
| Cedazuridine | 1141397-80-9 | Human | Under Development | |
| Cefaclor | 53994-73-3 | J Antiinfectives for Systemic Use | Human | Commercial |
| Cefaclor H2O | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Cefadroxil | 50370-12-2 | J Antiinfectives for Systemic Use | Human | Commercial |
| Cefadroxil H2O | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Cefazolin Acid | 25953-19-9 | J Antiinfectives for Systemic Use | Human | Commercial |
| Cefazolin Sodium | 27164-46-1 | J Antiinfectives for Systemic Use | Human | Commercial |
| Cefdinir H2O | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Cefepime | 88040-23-7 | Human | Commercial | |
| Cefixime | 79350-37-1 | J Antiinfectives for Systemic Use | Human | Commercial |
| Cefoperazone Sodium | 62893-19-0 | Human | Commercial | |
| Cefotaxime Sodium | 64485-93-4 | Human | Commercial | |
| Cefotetan Disodium | 69712-56-7 | Human | Commercial | |
| Cefoxitin Sodium | 33564-30-6 | Human | Commercial | |
| Cefprozil | 92665-29-7 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ceftazidime | 78439-06-2 | Human | Commercial | |
| Ceftibuten Dihydrate | 97519-39-6 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ceftriaxone Sodium | 104376-79-6 | Human | Commercial | |
| Cefuroxime Sodium | 56238-63-2 | Human | Commercial | |
| Celecoxib | 169590-42-5 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Celecoxib Form III | n.a. | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Celiprolol Hydrochloride | 57470-78-7 | C Cardiovascular System | Human | Commercial |
| Cenobamate | 913088-80-9 | N Nervous System | Human | Under Development |
| Cephalexin | 15686-71-2 | Human | Commercial | |
| Cephalexin H2O | n.a. | Human | Commercial | |
| Cephradine H2O | n.a. | D Dermatologicals | Human | Commercial |
| Cetirizine | 83881-51-0 | R Respiratory System | Human | Commercial |
| Cetirizine Dihydrochloride | 83881-52-1 | R Respiratory System | Human | Commercial |
| Cetirizine Hydrochloride | 83881-52-1 | R Respiratory System | Human | Commercial |
| Cetrorelix Acetate | 120287-85-6 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Cevimeline Hydrochloride | 153504-70-2 | N Nervous System | Human | Commercial |
| Chenodeoxycholic Acid | 474-25-9 | Human | Commercial | |
| Chlophedianol Hydrochloride | 1964-24-1 | Human | Commercial | |
| Chlorcyclizine Hydrochloride | 14362-31-3 | R Respiratory System | Human | Commercial |
| Chlordiazepoxide | 58-25-3 | N Nervous System | Human | Commercial |
| Chlordiazepoxide Hydrochloride | 438-41-5 | N Nervous System | Human | Commercial |
| Chlormadinone Acetate | 302-22-7 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Chlorobutanol Hemihydrate | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Chloroprocaine | 133-16-4 | N Nervous System | Human | Commercial |
| Chloropyramine | 59-32-5 | D Dermatologicals | Human | Commercial |
| Chloropyramine Hydrochloride | 6170-42-9 | D Dermatologicals | Human | Commercial |
| Chloroquine Phosphate | 50-63-5 | Human | Commercial | |
| Chlorothiazide | 58-94-6 | C Cardiovascular System | Human | Commercial |
| Chlorpromazine Hydrochloride | 69-09-0 | N Nervous System | Human | Commercial |
| Chlorprothixene Hydrochloride | 6469-93-8 | N Nervous System | Human | Commercial |
| Chlorthalidone | 77-36-1 | C Cardiovascular System | Human | Commercial |
| Chlorzoxazone | 95-25-0 | M Musculo-Skeletal System | Human | Commercial |
| Cholecalciferol | 67-97-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Cholic Acid | 81-25-4 | Human | Commercial | |
| Choline Fenofibrate | 856676-23-8 | Human | Commercial | |
| Cibenzoline Succinate | 138100-16-0 | Human | Commercial | |
| Cicletanine Hydrochloride | 89944-61-6 | C Cardiovascular System | Human | Commercial |
| Ciclopirox | 29342-05-0 | D Dermatologicals | Human | Commercial |
| Ciclopirox Olamine | 41621-49-2 | D Dermatologicals | Human | Commercial |
| Ciclosporine | 59865-13-3 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Cilastatin Sodium | 81129-83-1 | Human | Commercial | |
| Cilazapril | 88768-40-5 | C Cardiovascular System | Human | Commercial |
| Cilostazol | 73963-72-1 | B Blood and Blood Forming Organs | Human | Commercial |
| Cimetidine Form A | n.a. | Human | Commercial | |
| Cinacalcet | 226256-56-0 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Cinacalcet Hydrochloride | 364782-34-3 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Cinacalcet Hydrochloride Form I | n.a. | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Cinitapride Hydrogen Tartrate | 66564-14-5 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Ciprofibrate | 52214-84-3 | C Cardiovascular System | Human | Commercial |
| Ciprofioxacin Hydrochloride | 86393-32-0 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ciprofloxacin Hydrochloride H2O | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Cisatracurium Besylate | 96946-42-8 | M Musculo-Skeletal System | Human | Commercial |
| Cisplatin | 15663-27-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Citalopram | 59729-33-8 | N Nervous System | Human | Commercial |
| Citalopram Hydrobromide | 59729-32-7 | N Nervous System | Human | Commercial |
| Citalopram Hydrochloride | 59729-33-8 | N Nervous System | Human | Commercial |
| Citicholine | 987-78-0 | N Nervous System | Human | Commercial |
| Citicoline Sodium | 33818-15-4 | N Nervous System | Human | Commercial |
| Cladribine | 4291-63-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Clarithromycin | 81103-11-9 | J Antiinfectives for Systemic Use | Human | Commercial |
| Clascoterone | 19608-29-8 | D Dermatologicals | Human | Commercial |
| Clevidipine | 167221-71-8 | C Cardiovascular System | Human | Commercial |
| Clidinium Bromide | 3485-62-9 | Human | Commercial | |
| Clindamycin Hydrochloride | 21462-39-5 | D Dermatologicals | Human | Commercial |
| Clindamycin Palmitate Hydrochloride | 25507-04-4 | D Dermatologicals | Human | Under Development |
| Clindamycin Phosphate | 24729-96-2 | D Dermatologicals | Human | Commercial |
| Clindamycin Phosphate H2O | n.a. | D Dermatologicals | Human | Commercial |
| Clobazam | 22316-47-8 | N Nervous System | Human | Commercial |
| Clobenzorex Hydrochloride | 13364-32-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Clobetasol Propionate | 25122-46-7 | Human | Commercial | |
| Clobetasone Butyrate | 25122-46-7 | Human | Commercial | |
| Clocortolone Pivalate | 34097-16-0 | Human | Commercial | |
| Clodronic Acid Disodium NaCl Tetrahydrat | n.a. | Human | Commercial | |
| Clofarabine | 123318-82-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Clofazimine | 2030-63-9 | J Antiinfectives for Systemic Use | Human | Commercial |
| Clomiphene Citrate | 50-41-9 | Human | Commercial | |
| Clomipramine | 303-49-1 | N Nervous System | Human | Commercial |
| Clonazepam | 1622-61-3 | N Nervous System | Human | Commercial |
| Clonidine Base | 4205-90-7 | C Cardiovascular System | Human | Commercial |
| Clonidine Hydrochloride | 4205-91-8 | C Cardiovascular System | Human | Commercial |
| Clopidogrel | 113665-84-2 | B Blood and Blood Forming Organs | Human | Under Development |
| Clopidogrel Besylate | 120202-66-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Clopidogrel Bisulfate | 113665-84-2 | B Blood and Blood Forming Organs | Human | Commercial |
| Clopidogrel Bisulfate Form 1 | n.a. | B Blood and Blood Forming Organs | Human | Commercial |
| Clopidogrel Bisulfate Form I & Form Il | n.a. | B Blood and Blood Forming Organs | Human | Commercial |
| Clopidogrel Bisulfate Form II | n.a. | B Blood and Blood Forming Organs | Human | Commercial |
| Clopidogrel Hydrochloride | n.a. | B Blood and Blood Forming Organs | Human | Commercial |
| Clopidogrel Hydrogen Sulfate | 120202-66-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Clorazepate | 23887-31-2 | Human | Commercial | |
| Clotiazepam | 33671-46-4 | N Nervous System | Human | Commercial |
| Clotrimazole | 23593-75-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Cloxacillin Benzathine | n.a. | Human | Commercial | |
| Cloxacillin Sodium | 7081-44-9 | Human | Commercial | |
| Clozapine | 5786-21-0 | N Nervous System | Human | Commercial |
| Clyndamycin Phosphate | 24729-96-2 | D Dermatologicals | Human | Commercial |
| Cobamamide | 13870-90-1 | B Blood and Blood Forming Organs | Human | Commercial |
| Cobicistat | 1004316-88-4 | V Various | Human | Under Development |
| Cocaine Hydrochloride | 53-21-4 | N Nervous System | Human | Commercial |
| Codeine H2O | n.a. | R Respiratory System | Human | Commercial |
| Codeine Phosphate | 52-28-8 | R Respiratory System | Human | Commercial |
| Codeine Phosphate Hemihydrate | 41444-62-6 | R Respiratory System | Human | Commercial |
| Colchicine | 64-86-8 | M Musculo-Skeletal System | Human | Commercial |
| Colesevelam | 182815-43-6 | C Cardiovascular System | Human | Commercial |
| Copanlisib Hydrochloride | 1032568-63-0 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Corticotropin Acetate | 8001-08-5 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Under Development |
| Crisaborole | 906673-24-3 | D Dermatologicals | Human | Under Development |
| Crizotinib | 877399-52-5 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Cromolyn Sodium | 15826-37-6 | Human | Commercial | |
| Cyanocobalamin | 68-19-9 | Human | Commercial | |
| Cyclizine Base | 82-92-8 | R Respiratory System | Human | Commercial |
| Cyclizine Hydrochloride | 303-25-3 | R Respiratory System | Human | Commercial |
| Cyclobenzaprine | 303-53-7 | M Musculo-Skeletal System | Human | Commercial |
| Cyclobenzaprine Hydrochloride | 6202-23-9 | M Musculo-Skeletal System | Human | Commercial |
| Cyclodextrins / Betadex | 7585-39-9 | Human | Commercial | |
| Cyclofenil | 2624-43-3 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Cyclophosphamide | 50-18-0 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Cycloserine | 68-41-7 | J Antiinfectives for Systemic Use | Human | Commercial |
| Cyclosilicate | n.a. | Human | Under Development | |
| Cyproheptadine Hydrochloride 1.5H2O | 96496-40-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Cyproheptadine Orotate | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Cyproterone Acetate | 427-51-0 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Cysteamine Bitartrate | 56-17-7 | A Alimentary Tract and Metabolism | Human | Under Development |
| Cysteamine Hydrochloride | 156-57-0 | A Alimentary Tract and Metabolism | Human | Under Development |
| Cytarabine | 147-94-4 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Dabigatran | 211914-51-1 | Human | Commercial | |
| Dabigatran Etexilate | 211915-06-9 | Human | Commercial | |
| Dabigatran Etexilate Mesilate | 872728-81-9 | Human | Commercial | |
| Dabigatran Form I | n.a. | Human | Commercial | |
| Dacarbazine | 4342-03-4 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Daclatasvir | 1009119-64-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Dacomitinib | 1110813-31-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Dalbavancin | 171500-79-1 | J Antiinfectives for Systemic Use | Human | Commercial |
| Dalbavancin Hydrochloride | 171500-79-1 | J Antiinfectives for Systemic Use | Human | Commercial |
| Dalfampridine | 504-24-5 | Human | Commercial | |
| Dantrolenesodium | 14663-23-1 | Human | Commercial | |
| Dapagliflozin | 461432-26-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dapagliflozin Amorphous | n.a. | A Alimentary Tract and Metabolism | Human | Under Development |
| Dapagliflozin Propanediol | 960539-70-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Dapagliflozin Propanediol H2O | n.a. | A Alimentary Tract and Metabolism | Human | Under Development |
| Dapagliflozin S-Propanediol H2O | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Dapoxetine | 119356-77-3 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Dapoxetine Hydrochloride | 129938-20-1 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Daprodustat | 960539-70-2 | B Blood and Blood Forming Organs | Human | Under Development |
| Daptomycin | 103060-53-3 | J Antiinfectives for Systemic Use | Human | Commercial |
| Daridorexant | 1505484-82-1 | N Nervous System | Human | Under Development |
| Darifenacin Hydrobromide | 133099-07-7 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Darolutamide | 1297538-32-9 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Darunavir | 206361-99-1 | J Antiinfectives for Systemic Use | Human | Commercial |
| Darunavir Amorphous | n.a. | J Antiinfectives for Systemic Use | Human | Under Development |
| Darunavir Ethanolate | 635728-49-3 | J Antiinfectives for Systemic Use | Human | Commercial |
| Dasatinib | 302962-49-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Dasatinib H2O | n.a. | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Daunorubicin Hydrochloride | 23541-50-6 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Decitabine | 2353-33-5 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Declofenac Diethylammonium | 78213-16-8 | Human | Commercial | |
| Decoquinate | 18507-89-6 | Human | Commercial | |
| Deferasirox | 201530-41-8 | V Various | Human | Commercial |
| Deferoxamine Mesilate | 138-14-7 | V Various | Human | Commercial |
| Deflazacort | 14484-47-0 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Degarelix Acetate | 214766-78-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Dehydrated Alcohol | 64-17-5 | Human | Under Development | |
| Dehydrocholic Acid | 81-23-2 | Human | Commercial | |
| Delamanid | 681492-22-8 | J Antiinfectives for Systemic Use | Human | Under Development |
| Delapril Hydrochloride | 83435-67-0 | C Cardiovascular System | Human | Commercial |
| Delgocitinib | 1263774-59-9 | D Dermatologicals | Human | Under Development |
| Deogestrel | 54024-22-5 | Human | Commercial | |
| Deoxycholic Acid | 83-44-3 | Human | Commercial | |
| Deprodone Propionate | 5593-18-8 | Human | Commercial | |
| Dequalinium Chloride | 522-51-0 | Human | Commercial | |
| Desipramine Hydrochloride | 58-28-6 | N Nervous System | Human | Commercial |
| Desloratadine | 100643-71-8 | R Respiratory System | Human | Commercial |
| Desmopressin Acetate | 16679-58-6 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Desonide | 638-94-8 | D Dermatologicals | Human | Commercial |
| Desonide Sodium Phosphate | n.a. | D Dermatologicals | Human | Commercial |
| Desoximetasone | 382-67-2 | D Dermatologicals | Human | Commercial |
| Desoxycorticosterone | 64-85-7 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Desvenlafaxine | 93413-62-8 | N Nervous System | Human | Under Development |
| Desvenlafaxine Base | 93413-69-5 | N Nervous System | Human | Commercial |
| Desvenlafaxine Benzoate | 918408-78-9 | N Nervous System | Human | Commercial |
| Desvenlafaxine Succinate | 386750-22-7 | N Nervous System | Human | Commercial |
| Desvenlafaxine Succinate H2O | n.a. | N Nervous System | Human | Under Development |
| Deucravacitinib | 1609392-27-9 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Deuterated Tetrabenazine | n.a. | Human | Under Development | |
| Deutetrabenazine | 1392826-25-3 | N Nervous System | Human | Commercial |
| Dexamethasone | 50-02-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dexamethasone Acetate | 1177-87-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dexamethasone Acetate Anhydrous | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Dexamethasone Base | 50-02-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dexamethasone Sodium Phosphate | 55203-24-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dexamethasone-17, 21-Dipropionate | 5555-26-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dexamethasone-21-Isonicotinate | 2731-57-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dexamethasone-21-Phosphate Disodium NaCl | 2392-39-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dexamethasone-8 | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Dexamtahasone-17-valerate | 5021-43-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dexketoprofen Trometamol | 156604-79-4 | Human | Commercial | |
| Dexlansoprazole | 138530-94-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dex-lbuprofen | 51146-56-6 | Human | Commercial | |
| Dexmedetomidine Base | n.a. | N Nervous System | Human | Commercial |
| Dexmedetomidine Hydrochloride | 145108-58-3 | N Nervous System | Human | Commercial |
| Dexmethylphenidate | 40431-64-9 | N Nervous System | Human | Under Development |
| Dexmethylphenidate Hydrochloride | 19262-68-1 | N Nervous System | Human | Commercial |
| Dexrazoxane | 24584-09-6 | Human | Commercial | |
| Dextroamphetamine Saccharate | n.a. | Human | Commercial | |
| Dextroamphetamine Sulfate | 51-64-9 | Human | Commercial | |
| Dextromethorphan | 125-71-3 | R Respiratory System | Human | Commercial |
| Dextromethorphan Hydrobromide | 125-69-9 | R Respiratory System | Human | Commercial |
| Dextromethorphan Hydrobromide H2O | n.a. | R Respiratory System | Human | Under Development |
| Di Roximel Fumarate | Human | Commercial | ||
| Diacerein | 13739-02-1 | M Musculo-Skeletal System | Human | Commercial |
| Diamorphine Base | 561-27-3 | N Nervous System | Human | Commercial |
| Diamorphine Hydrochloride | 150-07-0 | N Nervous System | Human | Commercial |
| Diatrizoate Meglumine & Sodium | n.a. | Human | Commercial | |
| Diatrizoate Sodium | 737-31-5 | Human | Commercial | |
| Diazepam | 439-14-5 | N Nervous System | Human | Commercial |
| Diazoxide | 364-98-7 | C Cardiovascular System | Human | Commercial |
| Dibrompropamidine Isetionate | 614-87-9 | Human | Commercial | |
| Diclazuril | 101831-37-2 | Human | Under Development | |
| Diclofenac Deanol | n.a. | Human | Commercial | |
| Diclofenac Diethylamine | 78213-16-8 | Human | Commercial | |
| Diclofenac Epolamine | 119623-66-4 | Human | Commercial | |
| Diclofenac Free Acid | 15307-86-5 | Human | Commercial | |
| Diclofenac Potassium | 15307-81-0 | Human | Commercial | |
| Diclofenac Resinate | n.a. | Human | Commercial | |
| Diclofenac Sodium | 15307-79-6 | D Dermatologicals | Human | Commercial |
| Dicyclomine Hydrochloride | 67-92-5 | Human | Commercial | |
| Dicycloverine | 77-19-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Diethylamine Salicylate | 103-20-6 | Human | Commercial | |
| Diethylcarbamazine Citrate | 1642-54-2 | Human | Commercial | |
| Diethylpropione Hydrochloride | 134-80-5 | Human | Commercial | |
| Difelikefalin | 1024828-77-0 | V Various | Human | Under Development |
| Difenoxin Hydrochloride | 35607-36-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Diflorasone Diacetate | 2557-49-5 | Human | Commercial | |
| Diflucortolone Valerate | 59198-58-0 | Human | Commercial | |
| Diflunisal | 22494-42-4 | N Nervous System | Human | Commercial |
| Difluprednate | 23674-86-4 | D Dermatologicals | Human | Commercial |
| Dihydralazine Sulfate | 7327-87-9 | C Cardiovascular System | Human | Commercial |
| Dihydrocodeine Hydrogen Tartrate | 5965-13-9 | Human | Commercial | |
| Dihydroergocristine Mesilate | 17479-20-6 | C Cardiovascular System | Human | Commercial |
| Dihydroergotamine Mesilate | 6190-39-2 | N Nervous System | Human | Commercial |
| Dihydroergotoxine Mesilate | 8067-24-1 | N Nervous System | Human | Commercial |
| Dihydrotachysterol-2 | n.a. | Human | Commercial | |
| Diltiazem | 42399-41-7 | C Cardiovascular System | Human | Commercial |
| Diltiazem Hydrochloride | 33286-22-5 | C Cardiovascular System | Human | Commercial |
| Dimenhydrinate | 523-87-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dimethindene Maleate | Human | Commercial | ||
| Dimethyl Fumarate | 624-49-7 | Human | Commercial | |
| Di-Methylmethionine | Human | Commercial | ||
| Diosmin | 520-27-4 | C Cardiovascular System | Human | Commercial |
| Diphenhydramine | 58-73-1 | A Alimentary Tract and Metabolism | Human | Under Development |
| Diphenhydramine Citrate | 1668-19-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Diphenhydramine Hydrochloride | 147-24-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Diphenoxylate Hydrochloride | 3810-80-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dipyridamole | 58-32-2 | B Blood and Blood Forming Organs | Human | Commercial |
| Diroximel Fumarate | 1577222-14-0 | Human | Under Development | |
| Disulfiram | 97-77-8 | N Nervous System | Human | Commercial |
| Dithranol | 480-22-8 | D Dermatologicals | Human | Commercial |
| Divalproex Sodium | 76584-70-8 | Human | Commercial | |
| Dobutamine Hydrochloride | 49745-95-1 | C Cardiovascular System | Human | Commercial |
| Docetaxel | 114977-28-5 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Docetaxel Anhydrous | n.a. | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Docetaxel Trihydrate | n.a. | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Docosanol | 661-19-8 | D Dermatologicals | Human | Commercial |
| Dofetilide | 115256-11-6 | C Cardiovascular System | Human | Commercial |
| Dolasetron Mesilate | 115956-13-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Dolutegravir | 1051375-16-6 | J Antiinfectives for Systemic Use | Human | Under Development |
| Dolutegravir Sodium | 1051375-19-9 | J Antiinfectives for Systemic Use | Human | Under Development |
| Domperidone | 57808-66-9 | A Alimentary Tract and Metabolism | Human | Commercial |
| Domperidone Maleate | 83898-65-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Donepezil Hydrochloride | 120011-70-3 | N Nervous System | Human | Commercial |
| Donepezil Hydrochloride Form I | n.a. | N Nervous System | Human | Commercial |
| Donepezil Hydrochloride Form III | n.a. | N Nervous System | Human | Commercial |
| Dopamine Hydrochloride | 62-31-7 | C Cardiovascular System | Human | Commercial |
| Doravirine | 1338225-97-0 | J Antiinfectives for Systemic Use | Human | Under Development |
| Dorzolamide | 120279-96-1 | S Sensory Organs | Human | Commercial |
| Dorzolamide Hydrochloride | 130693-82-2 | S Sensory Organs | Human | Commercial |
| Dota | n.a. | Human | Commercial | |
| Doxazosin Mesilate | 77883-43-3 | C Cardiovascular System | Human | Commercial |
| Doxepin Hydrochloride | 1229-29-4 | D Dermatologicals | Human | Commercial |
| Doxercalciferol | 54573-75-0 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Doxophylline | 69975-86-6 | Human | Commercial | |
| Doxorubicin Hydrochloride | 25316-40-9 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Doxycycline H2O | n.a. | A Alimentary Tract and Metabolism | Human | Under Development |
| Doxycycline Hyclate | 24390-14-5 | A Alimentary Tract and Metabolism | Human | Under Development |
| Doxylamine | 469-21-6 | N Nervous System | Human | Commercial |
| Doxylamine Succinate | 562-10-7 | N Nervous System | Human | Commercial |
| Doxylamine Succinate Form I | n.a. | N Nervous System | Human | Commercial |
| D-Penicillamine | 52-67-5 | Human | Commercial | |
| Dronedarone | 141626-36-0 | C Cardiovascular System | Human | Commercial |
| Dronedarone Hydrochloride | 141625-93-6 | C Cardiovascular System | Human | Commercial |
| Drospirenone | 67392-87-4 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Droxidopa | 23651-95-8 | C Cardiovascular System | Human | Commercial |
| Duloxetine | 116539-59-4 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Duloxetine Hydrochloride | 136434-34-9 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Duloxetine Hydrochloride Form A | n.a. | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Dutasteride | 164656-23-9 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Duvelisib | 1201438-56-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Dydrogesterone | 152-62-5 | G Genito Urinary System and Sex Hormones | Human | Under Development |
| Eberconazole Nitrate | 128326-82-9 | Human | Commercial | |
| Echothiophate Iodide | 513-10-0 | Human | Under Development | |
| Econazole Nitrate | 24169-02-6 | Human | Commercial | |
| Edaravone | 89-25-8 | N Nervous System | Human | Commercial |
| Edoxaban | 480449-70-5 | B Blood and Blood Forming Organs | Human | Under Development |
| Edoxaban Tosylate | 480449-71-6 | Human | Under Development | |
| Edrophonium Chloride | 116-38-1 | Human | Commercial | |
| Efavirenz | 154598-52-4 | J Antiinfectives for Systemic Use | Human | Commercial |
| Efavirenz Form I | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Efinaconazole | 164650-44-6 | D Dermatologicals | Human | Commercial |
| Efonidipine Ethanolate Hydrochloride | n.a. | Human | Commercial | |
| Elagolix | 834153-87-6 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Elagolix Sodium | 832720-36-2 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Eletriptan Hydrobromide | 177834-92-3 | N Nervous System | Human | Commercial |
| Eletriptan Hydrobromide Form A | n.a. | N Nervous System | Human | Commercial |
| Eletriptan Hydrobromide H2O | n.a. | N Nervous System | Human | Commercial |
| Elexacaftor | 2216712-66-0 | Human | Under Development | |
| Eliglustat Hemitartrate | n.a. | Human | Under Development | |
| Eliglustat Tartrate | 928659-70-5 | Human | Under Development | |
| Elobixibat | 439087-18-0 | A Alimentary Tract and Metabolism | Human | Under Development |
| Eltrombopag | 496775-61-2 | B Blood and Blood Forming Organs | Human | Under Development |
| Eltrombopag Olamine | 496775-62-3 | B Blood and Blood Forming Organs | Human | Under Development |
| Eluxadoline | 864821-90-9 | A Alimentary Tract and Metabolism | Human | Under Development |
| Elvitegravir | 697761-98-1 | J Antiinfectives for Systemic Use | Human | Under Development |
| Elvitegravir Form III | n.a. | J Antiinfectives for Systemic Use | Human | Under Development |
| Empagliflozin | 864070-44-0 | A Alimentary Tract and Metabolism | Human | Under Development |
| Empagliflozin Amorphous / Crystalline | n.a. | A Alimentary Tract and Metabolism | Human | Under Development |
| Emtricitabine | 143491-57-0 | J Antiinfectives for Systemic Use | Human | Commercial |
| Enalapril Maleate | 76095-16-4 | Human | Commercial | |
| Enalaprilat | 76420-72-9 | Human | Commercial | |
| Enasidenib | 1446502-11-9 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Enasidenib Mesilate | 1446502-11-9 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Enavogliflozin | 1415472-28-4 | A Alimentary Tract and Metabolism | Human | Under Development |
| Enclomiphene Citrate | 15690-57-0 | Human | Commercial | |
| Encorafenib | 1269440-17-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Enoxaparin Sodium | 679809-58-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Entacapone | 130929-57-6 | N Nervous System | Human | Commercial |
| Entacapone Form A | n.a. | N Nervous System | Human | Commercial |
| Entecavir | 142217-69-4 | J Antiinfectives for Systemic Use | Human | Commercial |
| Entecavir H2O | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Entrectinib | 1108743-60-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Enviero Progesterone | Human | Commercial | ||
| Enzalutamide | 915087-33-1 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Eosine Sodium | 17372-87-1 | D Dermatologicals | Human | Commercial |
| Epacadostat | 1204669-58-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Epalrestat | 82159-09-9 | Human | Commercial | |
| Epinastine Hydrochloride | 80012-43-7 | R Respiratory System | Human | Commercial |
| Epinephrine | 51-43-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Epirubicin Hydrochloride | 56390-09-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Eplerenone | 107724-20-9 | C Cardiovascular System | Human | Commercial |
| Epoprostenol Sodium | 61849-14-7 | B Blood and Blood Forming Organs | Human | Commercial |
| Eprosartan Mesilate | 144143-96-4 | C Cardiovascular System | Human | Commercial |
| Eptifibatide | 188627-80-7 | B Blood and Blood Forming Organs | Human | Commercial |
| Erdafitinib | 1346242-81-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Erdosteine | 84611-23-4 | R Respiratory System | Human | Commercial |
| Ergocalciferol | 50-14-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ergometrine Ergonovine Maleate | 129-51-1 | Human | Commercial | |
| Ergotamine Tartrate | 379-79-3 | Human | Commercial | |
| Eribulin | 253128-41-5 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Erlotinib | 183321-74-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Erlotinib Hydrochloride | 183319-69-9 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Ertapenem | 153832-46-3 | Human | Commercial | |
| Ertugliflozin | 1210344-57-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Ertugliflozin L-Pyroglutamic Acid | 1210344-57-2 | Human | Under Development | |
| Erythromycin Base | 114-07-8 | D Dermatologicals | Human | Commercial |
| Erythromycin Ethyl Succinate | 1264-62-6 | D Dermatologicals | Human | Under Development |
| Escitalopram Oxalate | 219861-08-2 | Human | Commercial | |
| Eslicarbazepine | 104746-04-5 | N Nervous System | Human | Commercial |
| Eslicarbazepine Acetate | 236395-14-5 | N Nervous System | Human | Commercial |
| Esmolol Hydrochloride | 81161-17-3 | C Cardiovascular System | Human | Commercial |
| Esomeprazole | 119141-88-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Esomeprazole Mg | 217087-09-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Esomeprazole Mg Amorphous | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Esomeprazole Mg Dihydrate | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Esomeprazole Mg Trihydrate | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Esomeprazole Sodium | 161796-78-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Estazolam | 29975-16-4 | N Nervous System | Human | Commercial |
| Estradiol | 50-28-2 | D Dermatologicals | Human | Commercial |
| Estradiol Benzoate | 50-50-0 | D Dermatologicals | Human | Commercial |
| Estradiol Cypionate | 313-06-4 | D Dermatologicals | Human | Commercial |
| Estradiol Hemihydrate | 35380-71-3 | D Dermatologicals | Human | Commercial |
| Estradiol Valerate | 979-32-8 | D Dermatologicals | Human | Commercial |
| Estriol | 50-27-1 | G Genito Urinary System and Sex Hormones | Human | Under Development |
| Eszopiclone | 138729-47-2 | N Nervous System | Human | Commercial |
| Etelcalcitide | 1251156-22-7 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Ethacizine Hydrochloride | 562-02-3 | C Cardiovascular System | Human | Commercial |
| Ethacrynic Acid | 58-54-8 | Human | Commercial | |
| Ethambutol | 74-55-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ethanolamine Oleate | 3278-73-5 | Human | Commercial | |
| Ethinyl Estradiol | 57-63-6 | Human | Commercial | |
| Etizolam | 40054-69-1 | N Nervous System | Human | Commercial |
| Etodolac | 41340-25-4 | M Musculo-Skeletal System | Human | Commercial |
| Etomidate | 33125-97-2 | N Nervous System | Human | Commercial |
| Etonogestrel | 54048-10-1 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Etoposide | 33419-42-0 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Etoricoxib | 202409-33-4 | M Musculo-Skeletal System | Human | Commercial |
| Etoricoxib Form I | n.a. | M Musculo-Skeletal System | Human | Commercial |
| Etrasimod | 1206123-37-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Etravirine | 269055-15-4 | J Antiinfectives for Systemic Use | Human | Under Development |
| Etravirine Form I | n.a. | J Antiinfectives for Systemic Use | Human | Under Development |
| Etretinate | 54350-48-0 | D Dermatologicals | Human | Commercial |
| Everolimus | 159351-69-6 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Evobrutinib | 1415823-73-2 | Human | Under Development | |
| Exemestane | 107868-30-4 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Ezetimibe | 163222-33-1 | C Cardiovascular System | Human | Commercial |
| Famciclovir | 104227-87-4 | J Antiinfectives for Systemic Use | Human | Commercial |
| Famotidine | 76824-35-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Famotidine Form B | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Fampridine | 504-24-5 | N Nervous System | Human | Commercial |
| Fasoracetam | 110958-19-5 | Human | Commercial | |
| Favipiravir | 259793-96-9 | J Antiinfectives for Systemic Use | Human | Commercial |
| Febantel | 58306-30-2 | Human | Commercial | |
| Febuxostat | 144060-53-7 | M Musculo-Skeletal System | Human | Commercial |
| Febuxostat Form A | n.a. | M Musculo-Skeletal System | Human | Under Development |
| Fedratinib | 936091-26-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Felbamate | 25451-15-4 | N Nervous System | Human | Commercial |
| Felodipine | 72509-76-3 | C Cardiovascular System | Human | Commercial |
| Fenfluramine Hydrochloride | 404-82-0 | A Alimentary Tract and Metabolism | Human | Under Development |
| Fenofibrate | 49562-28-9 | C Cardiovascular System | Human | Commercial |
| Fenofibric Acid | 42017-89-0 | C Cardiovascular System | Human | Commercial |
| Fenofibric Acid - Choline NaCl | n.a. | C Cardiovascular System | Human | Commercial |
| Fenretinide | 65646-68-6 | Human | Under Development | |
| Fentanyl Base | 437-38-7 | N Nervous System | Human | Commercial |
| Fentanyl Citrate | 990-73-8 | N Nervous System | Human | Commercial |
| Fentanyl Hydrochloride | 1443-54-5 | N Nervous System | Human | Commercial |
| Fenticonazole Nitrate | 73151-29-8 | Human | Commercial | |
| Ferric Carboxymaltose | 9007-72-1 | Human | Commercial | |
| Ferric Citrate | 2338-05-8 | Human | Under Development | |
| Ferric Maltol | 33725-54-1 | Human | Under Development | |
| Ferrous Ascorbate | 24808-52-4 | Human | Under Development | |
| Ferumoxytol | 1309-38-2 | Human | Under Development | |
| Fesoterodine | 286930-03-8 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Fesoterodine Fumarate | 286930-03-8 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Fexofenadine Hydrochloride | 153439-40-8 | R Respiratory System | Human | Commercial |
| Fexofenadine Hydrochloride Form I | n.a. | R Respiratory System | Human | Commercial |
| Fezolinetant | 1629229-37-3 | G Genito Urinary System and Sex Hormones | Human | Under Development |
| Filgotinib Maleate | 1206161-97-8 | Human | Under Development | |
| Fimasartan Potassium | 247257-48-3 | Human | Commercial | |
| Finasteride | 98319-26-7 | D Dermatologicals | Human | Commercial |
| Finasteride Form I | n.a. | D Dermatologicals | Human | Commercial |
| Finerenone | 1050477-31-0 | C Cardiovascular System | Human | Under Development |
| Fingolimod Hydrochloride | 162359-56-0 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Flecainide Acetate | 54143-56-5 | C Cardiovascular System | Human | Commercial |
| Flibanserin | 167933-07-5 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Fluconazole | 86386-73-4 | D Dermatologicals | Human | Commercial |
| Flucytosin | 2022-85-7 | Human | Commercial | |
| Fludarabine Phosphate | 75607-67-9 | Human | Commercial | |
| Fludiazepam | 3900-31-0 | N Nervous System | Human | Commercial |
| Fludrocortisone Acetate | 514-36-3 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Fludrocortisone Base | 127-33-3 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Fludrocortisone-21-Acetate | 514-36-3 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Flugestone Acetate | 2529-45-5 | Human | Commercial | |
| Fluindione | 957-56-2 | B Blood and Blood Forming Organs | Human | Commercial |
| Flumazenil | 78755-81-4 | V Various | Human | Commercial |
| Flumethasone | 2135-17-3 | D Dermatologicals | Human | Commercial |
| Flumethasone Pivalate | 1251-87-2 | D Dermatologicals | Human | Commercial |
| Flunarizine Dihydrochloride | 30484-77-6 | N Nervous System | Human | Commercial |
| Flunisolide | 3385-03-3 | R Respiratory System | Human | Commercial |
| Flunisolide Anhydrous | 3385-03-3 | R Respiratory System | Human | Commercial |
| Flunisolide Hemihydrate | n.a. | R Respiratory System | Human | Commercial |
| Flunitrazepam | 1622-62-4 | N Nervous System | Human | Commercial |
| Fluocinolone Acetonide | 67-73-2 | Human | Commercial | |
| Fluocinonide | 356-12-7 | C Cardiovascular System | Human | Commercial |
| Fluocortolone Hexanoate Carproate | n.a. | Human | Commercial | |
| Fluocortolone Pivalate | 2269-97-2 | Human | Commercial | |
| Fluorescein Sodium | 518-47-8 | S Sensory Organs | Human | Commercial |
| Fluorometholone Acetate | 3801-06-7 | C Cardiovascular System | Human | Commercial |
| Fluorometholone Base | 426-13-1 | C Cardiovascular System | Human | Commercial |
| Fluoxetine Hydrochloride | 56296-78-7 | N Nervous System | Human | Commercial |
| Flupentixol Decanoate | 30906-68-0 | N Nervous System | Human | Commercial |
| Flupentixol Dihydrochloride | 2413-38-9 | N Nervous System | Human | Commercial |
| Fluphenazine Dihydrochloride | 146-56-5 | N Nervous System | Human | Commercial |
| Fluphenazine Hydrochloride | 146-56-5 | N Nervous System | Human | Commercial |
| Fluprednidene Acetate | 353-09-3 | D Dermatologicals | Human | Commercial |
| Flurandrenolide | 1524-88-5 | Human | Commercial | |
| Flurazepam | 17617-23-1 | Human | Commercial | |
| Flurbiprofen | 5104-49-4 | M Musculo-Skeletal System | Human | Under Development |
| Flutamide | 13311-84-7 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Fluticasone Furoate | 397864-44-7 | Human | Commercial | |
| Fluticasone Propionate | 80474-14-2 | Human | Commercial | |
| Fluvastatin Sodium | 93957-55-2 | C Cardiovascular System | Human | Commercial |
| Fluvoxamine | 54739-18-3 | N Nervous System | Human | Commercial |
| Fluvoxamine Maleate | 61718-82-9 | N Nervous System | Human | Commercial |
| Fmoc-l-7-azatrp-oh | n.a. | Human | Commercial | |
| Folic Acid | 59-30-3 | Human | Under Development | |
| Fondaparinux Sodium | 114870-03-0 | B Blood and Blood Forming Organs | Human | Commercial |
| Fonturacetam | 77472-70-9 | Human | Commercial | |
| Formoterol Fumarate | 183814-30-4 | Human | Commercial | |
| Formoterol Fumarate Dihydrate | 43229-80-7 | Human | Commercial | |
| Fosaprepitant | 172673-20-0 | Human | Under Development | |
| Fosaprepitant Dimeglumine | 265121-04-8 | Human | Commercial | |
| Foscarnet Sodium | 63585-09-1 | D Dermatologicals | Human | Commercial |
| Fosfomycin Calcium | 26472-47-9 | Human | Under Development | |
| Fosfomycin Trometamol | 78964-85-9 | Human | Commercial | |
| Fosfomycin Tromethamine | 78964-85-9 | Human | Commercial | |
| Fosinopril Sodium | 88889-14-9 | C Cardiovascular System | Human | Commercial |
| Fosnetupitant | 1703748-89-3 | Human | Commercial | |
| Fosphenytoin Sodium | 93390-81-9 | N Nervous System | Human | Commercial |
| Fostamatinib | 901119-35-5 | B Blood and Blood Forming Organs | Human | Under Development |
| Fostamatinib Disodium | 1025687-58-4 | B Blood and Blood Forming Organs | Human | Under Development |
| Fostemsavir | 864953-29-7 | J Antiinfectives for Systemic Use | Human | Under Development |
| Frovatriptan Succinate | 158930-17-7 | Human | Commercial | |
| Fulvestrant | 129453-61-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Fumarate | 110-17-8 | Human | Under Development | |
| Furosemide | 54-31-9 | C Cardiovascular System | Human | Commercial |
| Gabapentin | 60142-96-3 | N Nervous System | Human | Commercial |
| Gabapentin Enacarbil | 478296-72-9 | N Nervous System | Human | Commercial |
| Gadobutrol | 770691-21-9 | V Various | Human | Commercial |
| Gadopentetate Dimeglumine | 86050-77-8 | Human | Under Development | |
| Gadoterate Meglumine | 92943-93-6 | Human | Under Development | |
| Galantamine | 357-70-0 | N Nervous System | Human | Commercial |
| Galantamine Hydrobromide | 1953-04-4 | N Nervous System | Human | Commercial |
| Ganaxolone | 38398-32-2 | N Nervous System | Human | Under Development |
| Ganciclovir | 82410-32-0 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ganciclovir Sodium | 82410-32-0 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ganirelix Acetate | 123246-29-7 | N Nervous System | Human | Commercial |
| Garenoxacin | 194804-75-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Gatifloxacin | 112811-59-3 | J Antiinfectives for Systemic Use | Human | Commercial |
| Gefapixant | 1015787-98-0 | V Various | Human | Under Development |
| Gefitinib | 184475-35-2 | V Various | Human | Commercial |
| Gemcitabine | 95058-81-4 | B Blood and Blood Forming Organs | Human | Commercial |
| Gemcitabine Hydrochloride | 122111-03-9 | B Blood and Blood Forming Organs | Human | Commercial |
| Gemfibrozil | 25812-30-0 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Gentamycin Sulfate | 1405-41-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Gepirone | 83928-76-1 | Human | Under Development | |
| Gilteritinib | 1254053-43-4 | D Dermatologicals | Human | Under Development |
| Giredestrant | 1953133-47-5 | Human | Under Development | |
| Glacial Acetic Acid | 64-19-7 | Human | Under Development | |
| Glasdegib | 1095173-27-5 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Glatiramer Acetate | 147245-92-9 | Human | Commercial | |
| Glibenclamide | 10238-21-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Gliclazide | 21187-98-4 | M Musculo-Skeletal System | Human | Commercial |
| Glimepiride | 93479-97-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Glimepiride Form I | 93479-97-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Glipizide | 29094-61-9 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Glipizide Form I | 29094-61-9 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Gliquidone | 33342-05-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Glucagon Acetate | 16941-32-5 | A Alimentary Tract and Metabolism | Human | Under Development |
| Glucosamine Sulfate NaCl | 31284-96-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Glucose-1-Phosphate Disodium | 29994-86-3 | Human | Commercial | |
| Glyburide Form I | 10238-21-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Glycerol Phenylbutyrate | 611168-24-2 | Human | Commercial | |
| Glycopyrrolate | 596-51-0 | V Various | Human | Commercial |
| Glycopyrrolate Bromide | n.a. | Human | Commercial | |
| Glycopyrrolate Tosylate | n.a. | Human | Under Development | |
| Glycopyrronium Bromide | 596-51-0 | V Various | Human | Commercial |
| Gonadorelin Acetate | 34973-08-5 | V Various | Human | Commercial |
| Gonadorelin Diacetate | 33515-09-2 | V Various | Human | Commercial |
| Goserelin Acetate | 65807-02-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Granisetron | 109889-09-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Granisetron Base | 109889-09-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Granisetron Hydrochloride | 107007-99-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Guadecitabine | 929901-49-5 | Human | Under Development | |
| Guaifenesin | 93-14-1 | R Respiratory System | Human | Under Development |
| Guanfacine | 29110-47-2 | C Cardiovascular System | Human | Commercial |
| Guanfacine Hydrochloride | 29122-68-7 | C Cardiovascular System | Human | Commercial |
| Guanosine | 118-00-3 | Human | Commercial | |
| Halcinonide | 3093-35-4 | D Dermatologicals | Human | Commercial |
| Halobetasol Propionate | 66852-54-8 | Human | Commercial | |
| Halometasone H2O | n.a. | D Dermatologicals | Human | Commercial |
| Haloperidol | 52-86-8 | N Nervous System | Human | Commercial |
| Haloperidol Decanoate | 74050-97-8 | Human | Commercial | |
| Hcqs Sulfate | n.a. | Human | Under Development | |
| Heparin Sodium | 9041-08-1 | B Blood and Blood Forming Organs | Human | Commercial |
| Heptaminol Base | 372-66-7 | C Cardiovascular System | Human | Commercial |
| Heptaminol Hydrochloride | 543-15-7 | C Cardiovascular System | Human | Commercial |
| Hesperidin | 520-26-3 | Human | Commercial | |
| Hexetidine | 141-94-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Histamine Dihydrochloride | 56-92-8 | Human | Commercial | |
| Histamine Diphosphate H2O | n.a. | Human | Commercial | |
| Homatropine Hydrobromide | 51-56-9 | S Sensory Organs | Human | Commercial |
| Homatropine Methylbromide | 80-49-9 | S Sensory Organs | Human | Commercial |
| Hydralazine | 86-54-4 | C Cardiovascular System | Human | Commercial |
| Hydralazine Hydrochloride | 304-20-1 | C Cardiovascular System | Human | Commercial |
| Hydrochloroquine Sulfate | 747-36-4 | Human | Commercial | |
| Hydrochlorothiazide | 58-93-5 | C Cardiovascular System | Human | Commercial |
| Hydrocodone Bitartrate | 125-29-1 | Human | Commercial | |
| Hydrocortisone | 50-23-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydrocortisone Aceponate | 74050-20-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydrocortisone Acetate | 50-03-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydrocortisone Base | 50-23-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydrocortisone Hemisuccinate H2O | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydrocortisone Hydrogen Succinate | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydrocortisone Sodium Phosphate | 6006-62-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydrocortisone-17-Butyrate | 13609-67-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydrocortisone-21-Hemisuccinate | 2203-97-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydrocortisone-21-Phosphate Disodium NaCl | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydrocortisone-21-Sodium Succinate | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Hydromorphone Hydrochloride | 71-68-1 | N Nervous System | Human | Commercial |
| Hydroxocobalamin Acetate | 22465-48-1 | B Blood and Blood Forming Organs | Human | Commercial |
| Hydroxocobalamin Base | 13422-51-0 | B Blood and Blood Forming Organs | Human | Commercial |
| Hydroxocobalamin Hydrochloride | 13422-55-4 | B Blood and Blood Forming Organs | Human | Commercial |
| Hydroxocobalamin Sulfate | 13422-54-3 | B Blood and Blood Forming Organs | Human | Commercial |
| Hydroxycarbamide | 127-07-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Hydroxyethyl Salicylate | 87-28-5 | Human | Commercial | |
| Hydroxyurea | 127-07-1 | Human | Commercial | |
| Hydroxyzine Hydrochloride | 2192-20-3 | N Nervous System | Human | Commercial |
| Hydroxyzine Pamoate | 10250-27-8 | N Nervous System | Human | Under Development |
| Hymecromone | 90-33-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ibandronate Sodium | 138926-19-9 | Human | Commercial | |
| Ibrutinib | 936563-96-1 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ibuprofen | 15687-27-1 | C Cardiovascular System | Human | Commercial |
| Ibuprofen Lysinate | 57469-76-8 | C Cardiovascular System | Human | Commercial |
| Ibuprofen Sodium | 31121-93-4 | C Cardiovascular System | Human | Commercial |
| Ibuprofen Sodium Dihydrate | n.a. | C Cardiovascular System | Human | Commercial |
| Ibutilide Fumarate | 122647-32-9 | C Cardiovascular System | Human | Commercial |
| Icatibant | 130308-48-4 | B Blood and Blood Forming Organs | Human | Commercial |
| Icatibant Acetate | 138614-30-9 | B Blood and Blood Forming Organs | Human | Commercial |
| Icotinib Hydrochloride | 610798-31-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Idarubicin Hydrochloride | 57852-57-0 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Idelalisib | 870281-82-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Idrocilamide | 6961-46-2 | M Musculo-Skeletal System | Human | Commercial |
| Ifosfamide | 3778-73-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Iloperidone | 133454-47-4 | N Nervous System | Human | Commercial |
| Imatinib | 152459-95-5 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Imatinib Mesilate | 220127-57-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Imeglimin | 775351-65-0 | A Alimentary Tract and Metabolism | Human | Under Development |
| Imipenem and Cilastatin | n.a. | Human | Commercial | |
| Imipramine Hydrochloride | 113-52-0 | N Nervous System | Human | Commercial |
| Imiquimod | 99011-02-6 | D Dermatologicals | Human | Commercial |
| Indacaterol Acetate | 753498-25-8 | R Respiratory System | Human | Under Development |
| Indacaterol Maleate | 753498-20-3 | R Respiratory System | Human | Commercial |
| Indapamide | 26807-65-8 | C Cardiovascular System | Human | Commercial |
| Indigotindisulfonate Sodium | 860-22-0 | Human | Commercial | |
| Indobufen | 63610-08-2 | B Blood and Blood Forming Organs | Human | Commercial |
| Indocyanine Green | 3599-32-4 | Human | Commercial | |
| Indometacin | 53-86-1 | C Cardiovascular System | Human | Commercial |
| Indoximod | 110117-83-4 | Human | Commercial | |
| Infigratinib Phosphate | 1206109-54-5 | Human | Under Development | |
| Inosine | 58-63-9 | D Dermatologicals | Human | Commercial |
| Inosine Pranobex | 36703-88-5 | D Dermatologicals | Human | Commercial |
| Iobitridol | 136949-58-1 | V Various | Human | Under Development |
| Iodixanol | 92339-11-2 | V Various | Human | Under Development |
| Iohexol | 66108-95-0 | V Various | Human | Commercial |
| Iopamidol | 60166-93-0 | V Various | Human | Commercial |
| Ioversol | 87771-40-2 | V Various | Human | Under Development |
| Ipidacrine Hydrochloride H2O | n.a. | N Nervous System | Human | Commercial |
| Ipragliflozin | 761423-87-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ipratropium Bromide | 22254-24-6 | Human | Commercial | |
| Ipratropium Bromide H2O | n.a. | Human | Commercial | |
| Irbesartan | 138402-11-6 | C Cardiovascular System | Human | Commercial |
| Irbesartan Form A | n.a. | C Cardiovascular System | Human | Commercial |
| Irinotecan | 97682-44-5 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Irinotecan Hydrochloride | 100286-90-6 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Irinotecan Hydrochloride Trihydrate | 136572-09-3 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Iron III Hydroxide Polymaltose | 31714-29-9 | Human | Under Development | |
| Iron Sorbitol Dextrine Citric Acid | n.a. | Human | Commercial | |
| Iron Sucrose | 8047-67-4 | Human | Commercial | |
| Isavuconazol | 241479-67-4 | J Antiinfectives for Systemic Use | Human | Under Development |
| Isavuconazonium | 241479-67-4 | J Antiinfectives for Systemic Use | Human | Under Development |
| Isavuconazonium Sulfate | 946075-13-4 | J Antiinfectives for Systemic Use | Human | Commercial |
| Islatravir | 865363-93-5 | Human | Under Development | |
| Isoamyl Salycilate | 2050-08-0 | Human | Commercial | |
| Isoconazole Nitrate | 24168-96-5 | Human | Commercial | |
| Isopropamide Iodide | 71-81-8 | Human | Commercial | |
| Isoproterenol Hydrochloride | 5984-95-2 | Human | Commercial | |
| Isosorbide Mononitrate | 16051-77-7 | Human | Commercial | |
| Isosulfan Blue | 68238-36-8 | Human | Commercial | |
| Isotretinoin | 4759-48-2 | D Dermatologicals | Human | Commercial |
| Isoxsuprine Hydrochloride | 579-56-6 | C Cardiovascular System | Human | Commercial |
| Isradipine | 75695-93-1 | C Cardiovascular System | Human | Commercial |
| Istradefylline | 155270-99-8 | N Nervous System | Human | Commercial |
| Istradefylline Hydrochloride | 155270-99-8 | N Nervous System | Human | Under Development |
| Itopride Hydrochloride | 122892-31-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ivabradine Hydrochloride | 148849-67-6 | C Cardiovascular System | Human | Commercial |
| Ivacaftor | 873054-44-5 | R Respiratory System | Human | Commercial |
| Ivosidenib | 1448347-49-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ixazomib | 1072833-77-2 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ixazomib Citrate | 1239908-20-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ketamine | 6740-88-1 | N Nervous System | Human | Under Development |
| Ketamine Hydrochloride | 1867-66-9 | N Nervous System | Human | Commercial |
| Ketoconazole | 65277-42-1 | D Dermatologicals | Human | Commercial |
| Ketoprofen | 22071-15-4 | M Musculo-Skeletal System | Human | Commercial |
| Ketorolac Tromethamine | 74103-07-4 | Human | Commercial | |
| Ketotifen Hydrogen Fumarate | 34580-14-8 | Human | Commercial | |
| Labetalol | 36894-69-6 | C Cardiovascular System | Human | Commercial |
| Labetalol Hydrochloride | 32780-64-6 | C Cardiovascular System | Human | Commercial |
| Lacidipine | 103890-78-4 | C Cardiovascular System | Human | Commercial |
| Lacosamide | 175481-36-4 | N Nervous System | Human | Commercial |
| Lacosamide Form I | n.a. | N Nervous System | Human | Under Development |
| Lacosamide Hydrochloride | 175481-36-4 | N Nervous System | Human | Commercial |
| Lactulose | 4618-18-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Lafutidine | 118288-08-7 | A Alimentary Tract and Metabolism | Human | Under Development |
| Lamivudine | 134678-17-4 | J Antiinfectives for Systemic Use | Human | Commercial |
| Lamivudine Form I & Form Il | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Lamotrigine | 84057-84-1 | N Nervous System | Human | Commercial |
| Landiolol Hydrochloride | 144481-98-1 | C Cardiovascular System | Human | Commercial |
| Laninamivir Octanoate | 203120-54-7 | Human | Under Development | |
| Lanreotide Acetate | 127984-74-1 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Lansoprazole | 103577-45-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Lansoprazole Crystalline | 103577-45-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Lanthanum Carbonate | 54451-24-0 | Human | Commercial | |
| Lanthanum Carbonate H2O | n.a. | Human | Commercial | |
| Lapatinib | 231277-92-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Lapatinib Ditosylate | 388082-78-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Larotrectinib | 1223403-58-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Larotrectinib Sulfate | 1223403-58-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Lasmiditan | 439239-90-4 | N Nervous System | Human | Under Development |
| Lasmiditan Hemisuccinate | n.a. | N Nervous System | Human | Under Development |
| Lasmiditan Succinate | 439239-90-4 | N Nervous System | Human | Under Development |
| Latanoprostene Bunod | 860005-21-6 | Human | Commercial | |
| L-Carnosine | 305-84-0 | Human | Commercial | |
| Ledipasvir | 1256388-51-8 | Human | Under Development | |
| Leflunomide | 75706-12-6 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Lemborexant | 1369764-02-2 | N Nervous System | Human | Under Development |
| Lenalidomide | 191732-72-6 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Lenalidomide Form B | 191732-72-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Lenvatinib | 417716-92-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Lenvatinib Mesilate | 857890-39-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Lercanidipine | 100427-26-7 | C Cardiovascular System | Human | Commercial |
| Lercanidipine Hydrochloride | 132866-11-6 | C Cardiovascular System | Human | Commercial |
| Lercanidipine Hydrochloride Hemihydrate Amorphous | n.a. | C Cardiovascular System | Human | Commercial |
| Lesinurad | 878672-00-5 | M Musculo-Skeletal System | Human | Under Development |
| Lesinurad Sodium | 1151516-14-1 | M Musculo-Skeletal System | Human | Under Development |
| Letermovir | 917389-32-3 | J Antiinfectives for Systemic Use | Human | Under Development |
| Letrozole | 112809-51-5 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Leuprolide Acetate | 74381-53-6 | Human | Commercial | |
| Levalbuterol Hydrochloride | 34391-04-3 | Human | Commercial | |
| Levetiracetam | 102767-28-2 | N Nervous System | Human | Commercial |
| Levetiracetam Form I | n.a. | N Nervous System | Human | Commercial |
| Levetiracetam Form IV | n.a. | N Nervous System | Human | Commercial |
| Levobunolol Hydrochloride | 27912-14-7 | S Sensory Organs | Human | Commercial |
| Levobupivacaine | 27262-47-1 | N Nervous System | Human | Commercial |
| Levobupivacaine Hydrochloride | 27262-48-2 | N Nervous System | Human | Commercial |
| Levocabastine | 79516-68-0 | R Respiratory System | Human | Commercial |
| Levocetirizine Dihydrochloride | 130018-87-0 | R Respiratory System | Human | Commercial |
| Levodopa | 59-92-7 | N Nervous System | Human | Commercial |
| Levofloxacin | 100986-85-4 | J Antiinfectives for Systemic Use | Human | Commercial |
| Levofloxacin Hemihydrate | 177325-13-2 | J Antiinfectives for Systemic Use | Human | Commercial |
| Levoketoconazole | 142128-57-2 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Under Development |
| Levomethadone Hydrochloride | 5967-73-7 | N Nervous System | Human | Commercial |
| Levomilnacipran | 96847-55-1 | N Nervous System | Human | Commercial |
| Levomilnacipran Hydrochloride | 96847-55-1 | N Nervous System | Human | Commercial |
| Levonorgestrel | 797-63-7 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Levosalbutamol Hydrochloride Levalbuterol | 34391-04-3 | Human | Commercial | |
| Levo-Salbutamol Sulfate | n.a. | Human | Commercial | |
| Levo-Salbutamol Tartrate | n.a. | Human | Commercial | |
| Levosimendan | 141505-33-1 | C Cardiovascular System | Human | Commercial |
| Levosulpiride | 23672-07-3 | N Nervous System | Human | Commercial |
| Levothyroxine | 51-48-9 | V Various | Human | Commercial |
| Levothyroxine Sodium | 55-03-8 | V Various | Human | Commercial |
| Lidocaine | 137-58-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Lidocaine Base | 137-58-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Lidocaine Hydrochloride | 73-78-9 | A Alimentary Tract and Metabolism | Human | Commercial |
| Lifitegrast | 1025967-78-5 | S Sensory Organs | Human | Under Development |
| Linaclotide | 851199-59-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Linaclotide Acetate | 851199-59-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Linagliptin | 668270-12-0 | A Alimentary Tract and Metabolism | Human | Under Development |
| Linagliptin Form C | n.a. | A Alimentary Tract and Metabolism | Human | Under Development |
| Linezolid | 165800-03-3 | J Antiinfectives for Systemic Use | Human | Commercial |
| Linezolid Form I | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Linezolid Form II | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Linezolid Form III | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Linzagolix | 935283-04-8 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Under Development |
| Liothyronine Sodium | 55-06-1 | Human | Commercial | |
| Liraglutide | 204656-20-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Liraglutide Acetate | 204656-20-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Lisdexamfetamine Dimesylate | 608137-33-3 | Human | Commercial | |
| Lisinopril | 76547-98-3 | C Cardiovascular System | Human | Commercial |
| Lithium Carbonate | 10377-37-4 | Human | Commercial | |
| L-Lysine Aescinate | 61602-56-2 | Human | Commercial | |
| Lofexidine | 31036-80-3 | N Nervous System | Human | Commercial |
| Lofexidine Hydrochloride | 21498-08-8 | N Nervous System | Human | Under Development |
| Lomifylline | 10226-54-7 | Human | Commercial | |
| Lomitapide Mesilate | 202914-84-9 | C Cardiovascular System | Human | Commercial |
| Lomustine | 13010-47-4 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Loperamide Hydrochloride | 34552-83-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Lopinavir | 192725-17-0 | Human | Commercial | |
| Lopinavir Form I & Amorphous | n.a. | Human | Commercial | |
| Loratadine | 79794-75-5 | R Respiratory System | Human | Commercial |
| Lorazepam | 846-49-1 | C Cardiovascular System | Human | Commercial |
| Lorlatinib | 1454846-35-5 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Lormetazepam | 848-75-9 | N Nervous System | Human | Commercial |
| Lornoxicam | 70374-39-9 | M Musculo-Skeletal System | Human | Commercial |
| Losartan | 114798-26-4 | C Cardiovascular System | Human | Commercial |
| Losartan Mono Potassium | n.a. | C Cardiovascular System | Human | Commercial |
| Losartan Potassium | 124750-99-8 | C Cardiovascular System | Human | Commercial |
| Losartan Potassium Azide | n.a. | C Cardiovascular System | Human | Commercial |
| Losartan Potassium Form I | n.a. | C Cardiovascular System | Human | Commercial |
| Loteprednol Etabonate | 82034-46-6 | Human | Commercial | |
| Lovastatin | 75330-75-5 | C Cardiovascular System | Human | Commercial |
| Loxapine Base | 1977-10-2 | N Nervous System | Human | Commercial |
| Loxapine Hydrochloride | 1977-11-3 | N Nervous System | Human | Commercial |
| Loxapine Succinate | 1987-29-3 | N Nervous System | Human | Commercial |
| Loxoprofen | 68767-14-6 | M Musculo-Skeletal System | Human | Commercial |
| Loxoprofen Sodium | 80382-23-6 | M Musculo-Skeletal System | Human | Commercial |
| Lubiprostone | 333963-40-9 | A Alimentary Tract and Metabolism | Human | Commercial |
| Luliconazole | 187164-19-8 | D Dermatologicals | Human | Commercial |
| Lumacaftor | 936727-05-8 | Human | Under Development | |
| Lumateperone Tosylate | 1431278-49-6 | Human | Commercial | |
| Lurasidone | 367514-87-2 | N Nervous System | Human | Commercial |
| Lurasidone Hydrochloride | 367514-88-3 | N Nervous System | Human | Commercial |
| Lurbinectedin | 497871-47-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Lusutrombopag | 1110766-97-6 | B Blood and Blood Forming Organs | Human | Under Development |
| Lymecycline | 992-21-2 | J Antiinfectives for Systemic Use | Human | Commercial |
| Macitentan | 441798-33-0 | C Cardiovascular System | Human | Under Development |
| Mafenide Acetate | 138-39-6 | D Dermatologicals | Human | Commercial |
| Magensium Lactate Dihydrate | 18917-93-6 | Human | Commercial | |
| Maprotilline Hydrochloride | 10347-81-6 | N Nervous System | Human | Commercial |
| Maraviroc | 376348-65-1 | J Antiinfectives for Systemic Use | Human | Under Development |
| Maraviroc Potassium | n.a. | J Antiinfectives for Systemic Use | Human | Under Development |
| Maraviroc Potassium Form B & Amorphous | n.a. | J Antiinfectives for Systemic Use | Human | Under Development |
| Mavacamten | 1642288-47-8 | C Cardiovascular System | Human | Under Development |
| Maxacalcitol | 103909-75-7 | Human | Commercial | |
| Mebendazole Form A | n.a. | Human | Commercial | |
| Mebeverine Hydrochloride | 2753-45-9 | A Alimentary Tract and Metabolism | Human | Commercial |
| Mebhydroline Napadisylate | 22204-53-1 | Human | Commercial | |
| Mechlorethamine Hydrochloride | 55-86-7 | Human | Commercial | |
| Meclizine Hydrochloride | 1104-22-9 | A Alimentary Tract and Metabolism | Human | Commercial |
| Medrogestone | 977-79-7 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Medroxyprogesterone Acetate | 71-58-9 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Mefenamic Acid | 61-68-7 | Human | Commercial | |
| Mefloquine Hydrochloride | 51773-92-3 | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Megestrol Acetate | 595-33-5 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Melitracen Hydrochloride | 5118-29-6 | N Nervous System | Human | Commercial |
| Meloxicam | 71125-38-7 | M Musculo-Skeletal System | Human | Commercial |
| Melperone Hydrochloride | 1622-62-4 | N Nervous System | Human | Commercial |
| Melphalan Hydrochloride | 3223-07-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Memantine | 19982-08-2 | N Nervous System | Human | Commercial |
| Memantine Hydrochloride | 41100-52-1 | N Nervous System | Human | Commercial |
| Memantine Hydrochloride Form I | n.a. | N Nervous System | Human | Commercial |
| Menadione | 58-27-5 | B Blood and Blood Forming Organs | Human | Commercial |
| Menadione Sodium Bisulfite | 130-37-0 | B Blood and Blood Forming Organs | Human | Commercial |
| Mepenzolate Bromide | 76-90-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Meperidine Hydrochloride | 50-13-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Mepivacaine Hydrochloride | 1722-62-9 | N Nervous System | Human | Commercial |
| Meprobamate | 57-53-4 | N Nervous System | Human | Commercial |
| Mequitazine | 29216-28-2 | R Respiratory System | Human | Commercial |
| Meropenem | 96036-03-2 | Human | Commercial | |
| Mesalamine | 89-57-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Mesna | 19767-45-4 | R Respiratory System | Human | Commercial |
| Metaxalone | 1665-48-1 | Human | Commercial | |
| Metergoline | 17692-51-2 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Metformin | 657-24-9 | A Alimentary Tract and Metabolism | Human | Commercial |
| Metformin Blends | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Metformin Hydrochloride | 1115-70-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Metformin Hydrochloride Form A | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Metformin Hydrochloride Mg | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Methadone Hydrochloride | 1095-90-5 | N Nervous System | Human | Commercial |
| Methamphetamine Hydrochloride | 51-57-0 | N Nervous System | Human | Commercial |
| Methazolamide | 554-57-4 | S Sensory Organs | Human | Commercial |
| Methenamine Hexamine Hippurate | n.a. | Human | Commercial | |
| Methenamine Hippurate | 57147-90-7 | Human | Commercial | |
| Methimazole / Thiamazol | 60-56-0 | Human | Commercial | |
| Methocarbamol | 532-03-6 | M Musculo-Skeletal System | Human | Commercial |
| Methohexital | 151-83-7 | N Nervous System | Human | Commercial |
| Methotrexate | 59-05-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Methotrexate Disodium | 133073-73-9 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Methotrexate Sodium | 15475-24-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Methoxsalen | 298-81-7 | D Dermatologicals | Human | Commercial |
| Methoxyphenamine Hydrochloride | 5588-10-3 | R Respiratory System | Human | Commercial |
| Methylcobalamin | 13422-55-4 | Human | Commercial | |
| Methyldopa | 555-30-6 | Human | Commercial | |
| Methylene Blue | 61-73-4 | Human | Commercial | |
| Methylergonovine Maleate | 57432-60-9 | Human | Commercial | |
| Methylnaltraxone Bromide | 73232-52-7 | Human | Under Development | |
| Methylphenidate | 113-45-1 | N Nervous System | Human | Commercial |
| Methylphenidate Base | 113-45-1 | N Nervous System | Human | Commercial |
| Methylphenidate Hydrochloride | 298-59-9 | N Nervous System | Human | Commercial |
| Methylphenobarbital | 115-38-8 | N Nervous System | Human | Commercial |
| Methylprednisolone | 83-43-2 | D Dermatologicals | Human | Commercial |
| Methylprednisolone Aceponate | 86401-95-8 | D Dermatologicals | Human | Commercial |
| Methylprednisolone Hemisuccinate | 2921-57-5 | D Dermatologicals | Human | Commercial |
| Methylprednisolone Hydrogen Succinate | n.a. | D Dermatologicals | Human | Commercial |
| Methylprednisolone-21-Acetate | 53-36-1 | D Dermatologicals | Human | Commercial |
| Methylprednisolone-21-Sodium Succinate | 2375-03-3 | D Dermatologicals | Human | Commercial |
| Methyltestosterone | 58-18-4 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Metoclopramide Base | 364-62-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Metoclopramide Hydrochloride | 7232-21-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Metolazone | 17560-51-9 | C Cardiovascular System | Human | Commercial |
| Metopimazine | 14008-44-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Metoprolol Succinate | 98418-47-4 | Human | Commercial | |
| Metoprolol Tartrate | 56392-17-7 | Human | Commercial | |
| Metronidazole | 443-48-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Metyrosine | 672-87-7 | C Cardiovascular System | Human | Under Development |
| Mexiletine Hydrochloride | 5370-01-4 | C Cardiovascular System | Human | Commercial |
| Mg Oxybate | n.a. | Human | Commercial | |
| Mg Valproate | 62959-43-7 | Human | Commercial | |
| Mianserin | 24219-97-4 | N Nervous System | Human | Commercial |
| Mianserin Hydrochloride | 21535-47-7 | N Nervous System | Human | Commercial |
| Micafungin | 235114-32-6 | J Antiinfectives for Systemic Use | Human | Under Development |
| Micafungin Sodium | 208538-73-2 | J Antiinfectives for Systemic Use | Human | Commercial |
| Miconazole Base | 22916-47-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Miconazole Nitrate | 22832-87-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Micronized Purified Flavonoid Fraction | n.a. | Human | Commercial | |
| Midazolam | 59467-70-8 | N Nervous System | Human | Commercial |
| Midazolam Hydrochloride | 59467-96-8 | N Nervous System | Human | Commercial |
| Midazolam Maleate | 59467-94-6 | N Nervous System | Human | Commercial |
| Midodrine | 42794-76-3 | C Cardiovascular System | Human | Commercial |
| Midodrine Hydrochloride | 43218-56-0 | C Cardiovascular System | Human | Commercial |
| Midostaurin | 120685-11-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Mifepristone | 84371-65-3 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Migalastat | 108147-54-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Migalastat Hydrochloride | 75172-81-5 | A Alimentary Tract and Metabolism | Human | Under Development |
| Miglustat | 72599-27-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Milnacipran | 92623-85-3 | N Nervous System | Human | Commercial |
| Milnacipran Hydrochloride | 101152-94-7 | N Nervous System | Human | Commercial |
| Milrinone | 78415-72-2 | C Cardiovascular System | Human | Commercial |
| Milrinone Lactate | 78415-72-2 | C Cardiovascular System | Human | Under Development |
| Minocycline Hydrochloride | 13614-98-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Minodronic Acid | 180064-38-4 | Human | Commercial | |
| Minodronic Acid H2O | 735152-46-4 | Human | Commercial | |
| Minoxidil | 38304-91-5 | C Cardiovascular System | Human | Commercial |
| Mirabegron | 223673-61-8 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Mirabegron Alpha Form | n.a. | G Genito Urinary System and Sex Hormones | Human | Under Development |
| Mirogabalin | 1138245-13-2 | N Nervous System | Human | Under Development |
| Mirogabalin Besylate | 1138245-21-2 | N Nervous System | Human | Under Development |
| Mirtazapine | 85650-52-8 | N Nervous System | Human | Commercial |
| Misoprostol | 59122-46-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Mitomycin | 50-07-7 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Mivacurium Chloride Amorphous | n.a. | Human | Commercial | |
| Mizolastine | 108612-45-9 | R Respiratory System | Human | Commercial |
| Moclobemide | 71320-77-9 | N Nervous System | Human | Commercial |
| Modafinil | 68693-11-8 | N Nervous System | Human | Commercial |
| Moexipril Hydrochloride | 82586-52-5 | C Cardiovascular System | Human | Commercial |
| Molnupiravir | 2492423-29-5 | J Antiinfectives for Systemic Use | Human | Under Development |
| Mometasone Furoate | 83919-23-7 | Human | Commercial | |
| Mometasone Furoate Anhydrous | n.a. | Human | Commercial | |
| Mometasone Furoate H2O | n.a. | Human | Commercial | |
| Mometasone-17-Furoate Anhydrous | n.a. | Human | Commercial | |
| Monosulfiram | 95-05-6 | Human | Commercial | |
| Montelukast | 158966-92-8 | R Respiratory System | Human | Commercial |
| Montelukast Sodium | 151767-02-1 | R Respiratory System | Human | Commercial |
| Morniflumate | 65847-85-0 | M Musculo-Skeletal System | Human | Commercial |
| Morphine Hydrochloride | 52-26-6 | N Nervous System | Human | Commercial |
| Morphine Sulfate | 64-31-3 | N Nervous System | Human | Commercial |
| Morphine Sulfate 5H2O | 13489-07-7 | N Nervous System | Human | Commercial |
| Mosapride Citrate Dihydrate | 112885-42-4 | Human | Commercial | |
| Moxifloxacin H2O Hydrochloride | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Moxifloxacin Hydrochloride | 186826-86-8 | J Antiinfectives for Systemic Use | Human | Commercial |
| Moxifloxacin Hydrochloride H2O / Anhydrous | 186826-86-8 | J Antiinfectives for Systemic Use | Human | Commercial |
| Moxonidine | 75438-57-2 | C Cardiovascular System | Human | Commercial |
| Mupirocin | 12650-69-0 | D Dermatologicals | Human | Commercial |
| Mupirocin Calcium | 115074-43-6 | D Dermatologicals | Human | Commercial |
| Mycophenolate | 24280-93-1 | Human | Commercial | |
| Mycophenolate Mofetil | 115007-34-6 | Human | Commercial | |
| Mycophenolate Sodium | 37415-62-6 | Human | Commercial | |
| Nabilone | 51022-71-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Nabumetone | 42924-53-8 | M Musculo-Skeletal System | Human | Commercial |
| N-Acetylcysteine | 616-91-1 | Human | Commercial | |
| N-Acetyl-L-Carnosine | 56353-15-2 | Human | Commercial | |
| Nafamostat Mesilate | 81525-10-2 | Human | Commercial | |
| Nafcillin | 985-16-0 | Human | Commercial | |
| Nafronyl Oxalate | 42741-17-5 | Human | Commercial | |
| Naftidrofuryl Hydrogen Oxalate | 3200-06-4 | Human | Under Development | |
| Naftidrofuryl Oxalate | 3200-06-4 | Human | Commercial | |
| Naftifine Hydrochloride | 65473-14-5 | D Dermatologicals | Human | Commercial |
| Naftopidil | 57149-07-2 | Human | Commercial | |
| Nalbuphine Hydrochloride | 23277-43-2 | N Nervous System | Human | Commercial |
| Nalfurafine Hydrochloride | 152946-68-4 | V Various | Human | Commercial |
| Nalmefene Hydrochloride | 58895-64-0 | N Nervous System | Human | Commercial |
| Naloxegol Oxalate | 918087-78-8 | Human | Under Development | |
| Naloxone Hydrochloride | 357-08-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Naloxone Hydrochloride Dihydrate | 51481-60-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Naltrexone Base | 16590-41-3 | N Nervous System | Human | Commercial |
| Naltrexone Hydrochloride | 16676-29-2 | N Nervous System | Human | Commercial |
| Nandrolone Phenylpropionate | 62-90-8 | Human | Commercial | |
| Naphazoline Hydrochloride | 550-99-2 | R Respiratory System | Human | Commercial |
| Naproxen | 22204-53-1 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Naproxen Sodium | 26159-34-2 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Naratriptan Hydrochloride | 143388-64-1 | N Nervous System | Human | Commercial |
| Nateglinide | 105816-04-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Nateglinide Form H | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Nebivolol | 118457-14-0 | C Cardiovascular System | Human | Under Development |
| Nebivolol Hydrochloride | 152520-56-4 | C Cardiovascular System | Human | Commercial |
| Nefazodone | 83366-66-9 | N Nervous System | Human | Under Development |
| Nefopam | 13669-70-0 | N Nervous System | Human | Commercial |
| Nefopam Hydrochloride | 23327-57-3 | N Nervous System | Human | Commercial |
| Nelarabine | 121032-29-9 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Neohesperidin Dihydrochalcone | 20702-77-6 | Human | Commercial | |
| Neomycin Sulfate | 1405-10-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Neostigmine Methylsulphate | 51-60-5 | Human | Commercial | |
| Nepafenac | 78281-72-8 | S Sensory Organs | Human | Commercial |
| Neratinib | 698387-09-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Neratinib Maleate | 698387-09-6 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Netarsudil Dimesylate | 1446898-32-5 | S Sensory Organs | Human | Under Development |
| Netarsudil Mesilate | n.a. | S Sensory Organs | Human | Commercial |
| Nevirapine Form I | n.a. | Human | Commercial | |
| Niacin | 59-67-6 | Human | Commercial | |
| Nicardipine Hydrochloride | 54527-84-3 | C Cardiovascular System | Human | Commercial |
| Nicergoline | 27848-84-6 | C Cardiovascular System | Human | Commercial |
| Nicorandil | 65141-46-0 | C Cardiovascular System | Human | Commercial |
| Nifedipine | 21829-25-4 | C Cardiovascular System | Human | Commercial |
| Niflumic Acid | 4394-00-7 | Human | Commercial | |
| Nilotinib | 641571-10-0 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Nilotinib Fumarate | 641571-10-0 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Nilotinib Hydrochloride | 923288-90-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Nilotinib Hydrochloride H2O | n.a. | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Nilotinib Tartrate | n.a. | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Nimodipine | 66085-59-4 | C Cardiovascular System | Human | Commercial |
| Nimodipine Form A | n.a. | C Cardiovascular System | Human | Commercial |
| Nimorazole | 6506-37-2 | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Nintedanib | 656247-17-5 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Nintedanib Base | 656247-17-5 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Nintedanib Esylate | 656247-18-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Nintedanib Esylate Hemihydrate | n.a. | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Niraparib | 1038915-60-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Niraparib Tosylate | 1038915-60-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Niraparib Tosylate H2O | n.a. | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Nirmatrelvir | 2628280-40-8 | Human | Commercial | |
| Nisoldipine | 63675-72-9 | C Cardiovascular System | Human | Commercial |
| Nitisinone | 104206-65-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Nitrazepam | 146-22-5 | N Nervous System | Human | Commercial |
| Nitrendipine | 39562-70-4 | Human | Commercial | |
| Nitrofurantoin | 67-20-9 | J Antiinfectives for Systemic Use | Human | Commercial |
| Nitrofurantoin H2O | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Nitrofurantoin Macrocrystalline | 67-20-9 | J Antiinfectives for Systemic Use | Human | Commercial |
| Nizatidine | 76963-41-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Nomegestrol | 58691-88-6 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Nomegestrol Acetate | 58691-88-6 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Noradrenaline Bitartrate H2O | n.a. | Human | Commercial | |
| Noradrenaline Tartrate | n.a. | Human | Under Development | |
| Norepinephrine Bitartrate | 51-41-2 | Human | Commercial | |
| Norethindrone Base | 68-22-4 | Human | Commercial | |
| Norethisterone | 68-22-4 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Norethisterone Acetate | 51-98-9 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Norgestimate | 35189-28-7 | Human | Commercial | |
| Norgestrel | 6533-00-2 | Human | Commercial | |
| Nortriptyline Hydrochloride | 894-71-3 | N Nervous System | Human | Commercial |
| Novobiocin Sodium | 1476-53-5 | Human | Commercial | |
| Obeticholic Acid | 459789-99-2 | Human | Commercial | |
| Obidoxime Hydrochloride | 114-90-9 | V Various | Human | Commercial |
| Octenidine Dihydrochloride | 70775-75-6 | A Alimentary Tract and Metabolism | Human | Under Development |
| Octreotide | 83150-76-9 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Octreotide Acetate | 79517-01-4 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| O-Desmethyl Venlafaxine Base | 93413-62-6 | Human | Commercial | |
| O-Desmethyl Venlafaxine Succinate | 197591-33-0 | Human | Commercial | |
| Odevixibat Bylvay | 1594327-88-4 | Human | Under Development | |
| Olanzapine | 132539-06-1 | N Nervous System | Human | Commercial |
| Olanzapine Form I | n.a. | N Nervous System | Human | Commercial |
| Olanzapine Form II | n.a. | N Nervous System | Human | Commercial |
| Olaparib | 763113-22-0 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Olmesartan | 144689-24-7 | Human | Commercial | |
| Olmesartan Medoxomil | 144689-63-4 | Human | Commercial | |
| Olodaterol | 868049-49-4 | R Respiratory System | Human | Under Development |
| Olodaterol Hydrochloride | 869477-96-3 | R Respiratory System | Human | Commercial |
| Olopatadine | 113806-05-6 | R Respiratory System | Human | Commercial |
| Olopatadine Hydrochloride | 140462-76-6 | R Respiratory System | Human | Commercial |
| Olopatadine Hydrochloride Form I | 140462-76-6 | R Respiratory System | Human | Commercial |
| Omadacycline | 389139-89-3 | J Antiinfectives for Systemic Use | Human | Under Development |
| Omecamtiv Mecarbil | 873697-71-3 | Human | Under Development | |
| Omeprazole | 73590-58-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Omeprazole Form A & Form B | 73590-58-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Omeprazole Mg | 95382-33-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ondansetron | 99614-02-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ondansetron Base | 99614-02-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ondansetron Hydrochloride | 103639-04-9 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ondansetron Hydrochloride Dihydrate | 99614-01-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Opicapone | 923287-50-7 | N Nervous System | Human | Commercial |
| Opipramol Dihydrochloride | 315-72-0 | N Nervous System | Human | Commercial |
| Opium Tincture | 8001-61-4 | Human | Commercial | |
| Oritavancin | 171099-57-3 | J Antiinfectives for Systemic Use | Human | Commercial |
| Orlistat | 96829-58-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Orphenadrine Citrate | 4682-36-4 | Human | Commercial | |
| Orphenadrine Hydrochloride | 341-69-5 | Human | Commercial | |
| Oseltamivir | 196618-13-0 | J Antiinfectives for Systemic Use | Human | Commercial |
| Oseltamivir Phosphate | 204255-11-8 | J Antiinfectives for Systemic Use | Human | Commercial |
| Oseltamivir Phosphate Form A | 204255-11-8 | J Antiinfectives for Systemic Use | Human | Commercial |
| Osimertinib | 1421373-65-0 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Osimertinib Mesilate | 1421373-65-0 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Ospemifene | 128607-22-7 | G Genito Urinary System and Sex Hormones | Human | Under Development |
| Oteseconazole | 1340593-59-0 | J Antiinfectives for Systemic Use | Human | Under Development |
| Otilonium Bromide | 26095-59-0 | Human | Commercial | |
| Oxaliplatin | 61825-94-3 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Oxandrolone | 53-39-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Oxaprozin | 21256-18-8 | M Musculo-Skeletal System | Human | Commercial |
| Oxazepam | 604-75-1 | N Nervous System | Human | Commercial |
| Oxcarbazepine | 28721-07-5 | N Nervous System | Human | Commercial |
| Oxeladin Citrate | 4682-45-5 | Human | Commercial | |
| Oxiconazole | 64211-45-6 | D Dermatologicals | Human | Commercial |
| Oxiconazole Nitrate | 64211-46-7 | D Dermatologicals | Human | Commercial |
| Oxybutynin Base | 5633-20-5 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Oxybutynine Hydrochloride | 1508-65-2 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Oxycodone Base | 76-42-6 | N Nervous System | Human | Commercial |
| Oxycodone Hydrochloride | 124-90-3 | N Nervous System | Human | Commercial |
| Oxymetazoline Hydrochloride | 2315-02-8 | D Dermatologicals | Human | Commercial |
| Oxymorphone Hydrochloride | 357-07-3 | N Nervous System | Human | Commercial |
| Oxytocin | 50-56-6 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Oxytocin Acetate | 50-56-6# | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Ozagrel Hydrochloride | 75272-39-8 | Human | Commercial | |
| Ozagrel Sodium | 112645-23-5 | Human | Commercial | |
| Ozanimod | 1306760-87-1 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ozanimod Hydrochloride | 1306760-87-1 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ozenoxacin | 245765-41-7 | D Dermatologicals | Human | Commercial |
| Paclitaxel | 33069-62-4 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Palbociclib | 571190-30-2 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Paliperidone | 144598-75-4 | N Nervous System | Human | Commercial |
| Paliperidone Palmitate | 199739-10-1 | N Nervous System | Human | Commercial |
| Palonosetron Hydrochloride | 135729-62-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Palonosetron Hydrochloride Form l | A Alimentary Tract and Metabolism | Human | Commercial | |
| Pamidronic Acid | 40391-99-9 | Human | Commercial | |
| Pancuronium Bromide | 15500-66-0 | M Musculo-Skeletal System | Human | Commercial |
| Panrelipase | 53608-75-6 | Human | Under Development | |
| Pantoprazole Sodium | 138786-67-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Pantoprazole Sodium 1.5H2O | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Papaverine Hydrochloride | 61-25-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Paracetamol | 103-90-2 | N Nervous System | Human | Commercial |
| Paramethasone Acetate | 1185-37-5 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Paricalcitol | 131918-61-1 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Paroxetine Hydrochloride | 78246-49-8 | N Nervous System | Human | Commercial |
| Paroxetine Hydrochloride Anhydrous | 110429-35-1 | N Nervous System | Human | Commercial |
| Paroxetine Hydrochloride Hemihydrate | 110429-35-1 | N Nervous System | Human | Commercial |
| Patiromer Sorbitex Calcium | 1262333-17-6 | Human | Under Development | |
| Pazopanib | 444731-52-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Pazopanib Hydrochloride | 635702-64-6 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Peficitinib | 944118-01-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Pemafibrate | 848259-27-8 | C Cardiovascular System | Human | Under Development |
| Pemetrexed | 137281-23-3 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Pemetrexed Disodium | 150399-23-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Pemetrexed Disodium Hemipentahydrate | 357166-29-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Pemigatinib | 1513857-77-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Penciclovir | 39809-25-1 | D Dermatologicals | Human | Commercial |
| Penicillamine | 52-67-5 | M Musculo-Skeletal System | Human | Commercial |
| Penicillin G Benzathine 1% Lec., 0,2 % Tween | n.a. | M Musculo-Skeletal System | Human | Commercial |
| Penicillin G Potassium | 113-98-4 | M Musculo-Skeletal System | Human | Commercial |
| Penicillin G Potassium Buffered | 113-98-4 | M Musculo-Skeletal System | Human | Commercial |
| Penicillin G Procaine 1 % Lec. | 54-35-3 | M Musculo-Skeletal System | Human | Commercial |
| Penicillin G Sodium | 69-57-8 | M Musculo-Skeletal System | Human | Commercial |
| Penicillin V Benzathine 4 % Lec. | 132-93-4 | M Musculo-Skeletal System | Human | Commercial |
| Penicillin V Potassium | 132-98-9 | M Musculo-Skeletal System | Human | Commercial |
| Pentamidine Isethionate | 140-64-7 | Human | Commercial | |
| Pentoxifylline | 6493-05-6 | C Cardiovascular System | Human | Commercial |
| Perampanel | 380917-97-5 | N Nervous System | Human | Under Development |
| Pergolide | 66104-22-1 | N Nervous System | Human | Under Development |
| Pergolide Mesilate | 66104-23-2 | N Nervous System | Human | Commercial |
| Perhexiline Maleate | 6724-53-4 | Human | Commercial | |
| Perindopril Arginine | 159320-69-9 | Human | Commercial | |
| Perindopril Erbumine | 107133-36-8 | Human | Commercial | |
| Perindopril Tert-Butylamine | 107133-36-8 | Human | Commercial | |
| Permethrin | 52645-53-1 | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Perphenazine | 58-39-9 | N Nervous System | Human | Commercial |
| Pethidine Hydrochloride | 50-13-5 | N Nervous System | Human | Commercial |
| Phenazepam | 51753-57-2 | Human | Commercial | |
| Phenazopyridine Hydrochloride | 136-40-3 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Phendimetrazine Tartrate | 134-49-6 | Human | Commercial | |
| Phenelzine Sulfate | 156-51-4 | N Nervous System | Human | Commercial |
| Pheniramine Maleate | 132-20-7 | Human | Commercial | |
| Phenobarbital | 50-06-6 | N Nervous System | Human | Commercial |
| Phentermine Hydrochloride | 1197-21-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Phenylbutazone | 50-33-9 | M Musculo-Skeletal System | Human | Commercial |
| Phenylephrine | 59-42-7 | C Cardiovascular System | Human | Commercial |
| Phenylephrine Hydrochloride | 61-76-7 | C Cardiovascular System | Human | Commercial |
| Phenyltoloxamine Citrate | 518-92-3 | Human | Commercial | |
| Phenyramidol Hydrochloride | 522-45-4 | M Musculo-Skeletal System | Human | Commercial |
| Phenytoin | 57-41-0 | N Nervous System | Human | Commercial |
| Phenytoin Sodium | 630-93-3 | N Nervous System | Human | Commercial |
| Phloroglucinol | 108-73-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Pholcodine | 509-67-1 | R Respiratory System | Human | Commercial |
| Pholcodine H2O | 509-67-1 | R Respiratory System | Human | Commercial |
| Phytonadione | 84-80-0 | Human | Commercial | |
| Picloxydine Dihydrochloride | n.a. | S Sensory Organs | Human | Commercial |
| Pimavanserin | 706779-91-1 | N Nervous System | Human | Under Development |
| Pimavanserin Hemitartrate | n.a. | Human | Under Development | |
| Pimavanserin Tartrate | n.a. | Human | Under Development | |
| Pimecrolimus | 137071-32-0 | D Dermatologicals | Human | Commercial |
| Pinaverium Bromide | 53251-94-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Pindolol | 13523-86-9 | C Cardiovascular System | Human | Commercial |
| Pioglitazone | 111025-46-8 | A Alimentary Tract and Metabolism | Human | Under Development |
| Pioglitazone Hydrochloride | 112529-15-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Pioglitazone Hydrochloride Form I Anhydrous | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Pipamperone Dihydrochloride | 2448-09-5 | N Nervous System | Human | Commercial |
| Piperacillin H2O | n.a. | J Antiinfectives for Systemic Use | Human | Commercial |
| Piperacillin Sodium | 59703-84-3 | J Antiinfectives for Systemic Use | Human | Commercial |
| Piperaquine Phosphate | 4085-31-8 | Human | Commercial | |
| Piperidolate Hydrochloride | 129-77-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Pipoxolan Hydrochloride | n.a. | Human | Commercial | |
| Piretanide | 55837-27-9 | C Cardiovascular System | Human | Commercial |
| Pirfenidone | 53179-13-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Piribedil | 3605-01-4 | C Cardiovascular System | Human | Under Development |
| Piroxicam | 36322-90-4 | M Musculo-Skeletal System | Human | Commercial |
| Pitavastatin | 147511-69-1 | C Cardiovascular System | Human | Commercial |
| Pitavastatin Calcium | 147511-69-1 | C Cardiovascular System | Human | Under Development |
| Pitavastatin Calcium Form A | n.a. | C Cardiovascular System | Human | Under Development |
| Pitofenone Hydrochloride | 32997-55-2 | N Nervous System | Human | Commercial |
| Pitolisant | 362665-56-3 | N Nervous System | Human | Under Development |
| Pitolisant Hydrochloride | 903576-44-3 | N Nervous System | Human | Commercial |
| Pizotifen Malate | 15574-96-6 | Human | Commercial | |
| Plecanatide | 467426-54-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Plecanatide Acetate | 467426-54-6 | A Alimentary Tract and Metabolism | Human | Under Development |
| Plerixafor | 110078-46-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Podophyllotoxin | 518-28-5 | D Dermatologicals | Human | Commercial |
| Polistirex | 9003-49-0 | Human | Commercial | |
| Polyquat1 | n.a. | Human | Commercial | |
| Pomalidomide | 19171-19-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Ponatinib | 943319-70-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ponatinib Hydrochloride | 1114544-31-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ponesimod | 854107-55-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Posaconazole | 171228-49-2 | J Antiinfectives for Systemic Use | Human | Commercial |
| Posaconazole Form 1 | 171228-49-2 | J Antiinfectives for Systemic Use | Human | Under Development |
| Potassium Clavulanate and Cellulose Microcrystalline 1:1 | n.a. | Human | Commercial | |
| Potassium Clavulanate and Silicon Dioxide1:1 | n.a. | Human | Commercial | |
| Potassium Oxybate | 128-23-4 | Human | Commercial | |
| Pralatrexate | 146464-95-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Pralidoxime Chloride | 51-15-0 | Human | Commercial | |
| Pralidoxime Iodide | 94-63-3 | Human | Commercial | |
| Pralsetinib | 2097132-94-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Pramipexole | 104632-26-0 | N Nervous System | Human | Commercial |
| Pramipexole Base | 104632-25-9 | N Nervous System | Human | Commercial |
| Pramipexole Dihydrochloride | 104632-25-9 | N Nervous System | Human | Commercial |
| Pramipexole Dihydrochloride H2O | n.a. | N Nervous System | Human | Commercial |
| Prasterone | 53-43-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Prasugrel | 150322-43-3 | B Blood and Blood Forming Organs | Human | Commercial |
| Prasugrel Base | 150322-43-3 | B Blood and Blood Forming Organs | Human | Commercial |
| Prasugrel Hydrobromide | n.a. | B Blood and Blood Forming Organs | Human | Commercial |
| Prasugrel Hydrochloride | 389574-19-0 | B Blood and Blood Forming Organs | Human | Commercial |
| Prasugrel Hydrochloride Form B1 | n.a. | B Blood and Blood Forming Organs | Human | Commercial |
| Pravastatin Sodium | 81131-70-6 | C Cardiovascular System | Human | Commercial |
| Prazepam | 2955-38-6 | N Nervous System | Human | Commercial |
| Prazosin | 19216-56-9 | C Cardiovascular System | Human | Commercial |
| Prazosin Hydrochloride | 19237-84-4 | C Cardiovascular System | Human | Commercial |
| Prednicarbate | 73771-04-7 | D Dermatologicals | Human | Commercial |
| Prednisolone | 50-24-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Prednisolone Acetate | 52-21-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Prednisolone Base | 50-24-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Prednisolone Hemisuccinate | 125-02-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Prednisolone Hexanoate Carproate | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Prednisolone Sodium Metasulfobenzoate | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Prednisolone Valerate Acetate | 36618-65-2 | A Alimentary Tract and Metabolism | Human | Commercial |
| Prednisolone-21-Phosphate Disodium NaCl | n.a. | A Alimentary Tract and Metabolism | Human | Commercial |
| Pregabalin | 148553-50-8 | N Nervous System | Human | Commercial |
| Pretomanid | 187235-37-6 | J Antiinfectives for Systemic Use | Human | Under Development |
| Pridinol Mesilate | 511-64-8 | M Musculo-Skeletal System | Human | Commercial |
| Prilocaine Base | 721-50-6 | N Nervous System | Human | Commercial |
| Prilocaine Hydrochloride | 1786-81-8 | N Nervous System | Human | Commercial |
| Primaquine Phosphate | 63-45-6 | Human | Commercial | |
| Primidone | 125-33-7 | N Nervous System | Human | Under Development |
| Probenecid | 57-66-9 | M Musculo-Skeletal System | Human | Commercial |
| Procaine Hydrochloride | 51-05-8 | C Cardiovascular System | Human | Commercial |
| Procaterol Hydrochloride Hemihydrate | 81262-93-3 | R Respiratory System | Human | Commercial |
| Prochlorperazine Edisylate | 1257-78-9 | Human | Commercial | |
| Procyclidine Hydrochloride | 1508-76-5 | N Nervous System | Human | Commercial |
| Progesterone | 57-83-0 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Proguanil Hydrochloride | 637-32-1 | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Promazine Hydrochloride | 53-60-1 | N Nervous System | Human | Commercial |
| Promethazine | 60-87-7 | D Dermatologicals | Human | Commercial |
| Propacetamol Hydrochloride | 66532-86-3 | N Nervous System | Human | Commercial |
| Propafenone Hydrochloride | 34183-22-7 | C Cardiovascular System | Human | Commercial |
| Propamidine Isetionate | 140-63-6 | Human | Commercial | |
| Propiomazine Maleate | 3568-24-9 | Human | Commercial | |
| Propiverine Hydrochloride | 54556-98-8 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Propofol | 2078-54-8 | N Nervous System | Human | Commercial |
| Propranolol | 525-66-6 | C Cardiovascular System | Human | Under Development |
| Propranolol Hydrochloride | 318-98-9 | C Cardiovascular System | Human | Commercial |
| Propyphenazone | 479-92-5 | N Nervous System | Human | Commercial |
| Protriptyline Hydrochloride | 1225-55-4 | N Nervous System | Human | Commercial |
| Prucalopride | 179474-81-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Prucalopride Succinate | 179474-81-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Pyrazinamide | 98-96-4 | J Antiinfectives for Systemic Use | Human | Commercial |
| Pyridostigmine Bromide | 101-26-8 | N Nervous System | Human | Commercial |
| Pyridoxal-5-Phosphate | 54-47-7 | Human | Commercial | |
| Pyridoxine | 65-23-6 | Human | Commercial | |
| Pyrimethamine | 58-14-0 | P Antiparasitic Products, Insecticides and Repellents | Human | Commercial |
| Pyrotinib Maleate | 1391490-85-8 | Human | Under Development | |
| Quetiapine Fumarate | 111974-72-2 | Human | Commercial | |
| Quetiapine Fumarate Form I | 111974-72-2 | Human | Commercial | |
| Quetiapine Hemifumarate | 111974-72-2 | Human | Commercial | |
| Quinapril Hydrochloride | 82586-55-8 | C Cardiovascular System | Human | Commercial |
| Rabeprazole Sodium | 117976-90-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Rabeprazole Sodium H2O | 117976-90-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Racecadotril | 81110-73-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Racepinephrine Hydrochloride | 329-63-5 | C Cardiovascular System | Human | Commercial |
| Ralinepag | 1187856-49-0 | Human | Under Development | |
| Raloxifene | 84449-90-1 | G Genito Urinary System and Sex Hormones | Human | Under Development |
| Raloxifene Hydrochloride | 82640-04-8 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Raltegravir | 518048-05-0 | J Antiinfectives for Systemic Use | Human | Commercial |
| Raltegravir Form I | 518048-05-0 | J Antiinfectives for Systemic Use | Human | Under Development |
| Raltegravir Form II | 518048-05-0 | J Antiinfectives for Systemic Use | Human | Under Development |
| Raltegravir Potassium | 871038-72-1 | J Antiinfectives for Systemic Use | Human | Under Development |
| Raltegravir Potassium Form III | n.a. | J Antiinfectives for Systemic Use | Human | Under Development |
| Ramelteon | 196597-26-9 | N Nervous System | Human | Commercial |
| Ramipril | 87333-19-5 | C Cardiovascular System | Human | Commercial |
| Ranitidine | 66357-35-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ranitidine Hydrochloride Form I | 66357-35-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ranitidine Hydrochloride Form II | 66357-35-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Ranolazine | 95635-55-5 | C Cardiovascular System | Human | Commercial |
| Ranolazine Crystalline | 95635-55-5 | C Cardiovascular System | Human | Commercial |
| Rasagiline Mesilate | 161735-79-1 | N Nervous System | Human | Commercial |
| Rasagiline Tartrate | 136236-51-0 | N Nervous System | Human | Commercial |
| R-Baclofen | 1134-47-0 | Human | Commercial | |
| Rebamipide | 90098-04-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Regadenoson | 313348-27-5 | C Cardiovascular System | Human | Under Development |
| Regadenoson Anhydrous | 313348-27-5 | C Cardiovascular System | Human | Under Development |
| Regadenoson Form C | 313348-27-5 | C Cardiovascular System | Human | Commercial |
| Regadenoson H2O | 313348-27-5 | C Cardiovascular System | Human | Under Development |
| Regorafenib | 755037-03-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Relebactam | 1174018-99-5 | Human | Under Development | |
| Relugolix | 737789-87-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Remdesivir | 1809249-37-3 | J Antiinfectives for Systemic Use | Human | Under Development |
| Remifentanil Hydrochloride | 132539-07-2 | N Nervous System | Human | Commercial |
| Remimazolam | 308242-62-8 | N Nervous System | Human | Under Development |
| Remimazolam Besylate | 308242-62-8 | N Nervous System | Human | Under Development |
| Repaglinide Form I | 135062-02-1 | Human | Commercial | |
| Revefenacin | 864750-70-9 | R Respiratory System | Human | Under Development |
| Ribavirin | 36791-04-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ribociclib | 1211441-98-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ribociclib Succinate | 1211441-98-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Rifabutin | 72559-06-9 | J Antiinfectives for Systemic Use | Human | Commercial |
| Rifampicin | 13292-46-1 | J Antiinfectives for Systemic Use | Human | Commercial |
| Rifamycin SV Sodium | 14897-39-3 | Human | Commercial | |
| Rifapentine | 61379-65-5 | J Antiinfectives for Systemic Use | Human | Under Development |
| Rifaximin | 80621-81-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Rilmenidine Dihydrogenphosphate | 54187-05-2 | Human | Commercial | |
| Rilpivirine | 500287-72-9 | J Antiinfectives for Systemic Use | Human | Under Development |
| Rilpivirine Hydrochloride | 866621-75-2 | J Antiinfectives for Systemic Use | Human | Under Development |
| Riluzole | 1744-22-5 | N Nervous System | Human | Commercial |
| Rimantadine Hydrochloride | 1501-84-4 | J Antiinfectives for Systemic Use | Human | Commercial |
| Rimegepant | 1289023-67-1 | N Nervous System | Human | Under Development |
| Rimegepant Sulfate | 1289023-66-0 | N Nervous System | Human | Under Development |
| Riociguat | 625115-55-1 | C Cardiovascular System | Human | Under Development |
| Ripasudil | 223645-67-8 | S Sensory Organs | Human | Under Development |
| Ripretinib | 1442472-39-0 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Risdiplam | 1825352-65-5 | M Musculo-Skeletal System | Human | Under Development |
| Risedronate Sodium | 115436-72-1 | Human | Commercial | |
| Risperidone | 106266-06-2 | N Nervous System | Human | Commercial |
| Ritlecitinib | 1792180-81-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Ritonavir | 155213-67-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ritonavir Form I | 155213-67-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Ritonavir Form II | 155213-67-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Rivaroxaban | 366789-02-8 | B Blood and Blood Forming Organs | Human | Commercial |
| Rivastigmine | 123441-03-2 | N Nervous System | Human | Commercial |
| Rivastigmine Base | 123441-03-2 | N Nervous System | Human | Commercial |
| Rivastigmine Hydrogen Tartrate | 129101-54-8 | N Nervous System | Human | Commercial |
| Rivastigmine Tartrate | 129101-54-8 | N Nervous System | Human | Commercial |
| Rizatriptan Benzoate | 145202-66-0 | Human | Commercial | |
| R-Ketamine | 6740-88-1 | Human | Under Development | |
| Rocuronium Bromide | 119302-91-9 | Human | Commercial | |
| Roflumilast | 162401-32-3 | D Dermatologicals | Human | Commercial |
| Romidepsin | 128517-07-7 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Ropinirole Hydrochloride | 91374-21-9 | N Nervous System | Human | Commercial |
| Ropinirole L-ICI | n.a. | Human | Commercial | |
| Ropivacaine Base | 98717-15-8 | N Nervous System | Human | Commercial |
| Ropivacaine Hydrochloride | 132112-35-7 | N Nervous System | Human | Commercial |
| Ropivacaine Hydrochloride Anhydrous | 132112-35-7 | N Nervous System | Human | Commercial |
| Ropivacaine Hydrochloride H2O | 132112-35-7 | N Nervous System | Human | Commercial |
| Rosuvastatin | 287714-41-4 | C Cardiovascular System | Human | Commercial |
| Rosuvastatin Calcium | 147098-20-2 | C Cardiovascular System | Human | Commercial |
| Rosuvastatin Calcium Amorphous | 147098-20-2 | C Cardiovascular System | Human | Commercial |
| Rosuvastatin Calcium Crystalline | 147098-20-2 | C Cardiovascular System | Human | Commercial |
| Rotigotine | 99755-59-6 | N Nervous System | Human | Commercial |
| Rotigotine Form II | 99755-59-6 | N Nervous System | Human | Under Development |
| Roxadustat | 808118-40-3 | B Blood and Blood Forming Organs | Human | Commercial |
| Roxatidine | 78273-80-0 | A Alimentary Tract and Metabolism | Human | Under Development |
| Roxithromycin | 80214-83-1 | J Antiinfectives for Systemic Use | Human | Commercial |
| Rucaparib Camsylate | 459856-18-9 | Human | Under Development | |
| Rufinamide | 106308-44-5 | N Nervous System | Human | Commercial |
| Rupatadine Fumarate | 182349-12-8 | Human | Under Development | |
| Ruxolitinib | 941678-49-5 | D Dermatologicals | Human | Under Development |
| Ruxolitinib Phosphate | 1092939-17-7 | D Dermatologicals | Human | Under Development |
| S - Amlodipine | 88150-42-9 | Human | Under Development | |
| S - Amlodipine Besylate | 111470-99-6 | Human | Commercial | |
| S - Atenolol | 29122-68-7 | Human | Commercial | |
| S - Etodolac | 41340-25-4 | Human | Under Development | |
| S - Ibuprofen | 51146-56-6 | Human | Under Development | |
| S - Ketamine Hydrochloride | 1867-66-9 | N Nervous System | Human | Commercial |
| S - lbuprofen | 51146-56-6 | Human | Commercial | |
| S - Methoprene | 40596-69-8 | Human | Commercial | |
| S - Metoprolol | 37350-58-6 | Human | Under Development | |
| S -Pantoprazole Sodium | 138786-67-1 | Human | Commercial | |
| Sacbitril Sodium NaCl | 149115-47-3 | Human | Under Development | |
| Sacubitril | 149709-62-6 | Human | Commercial | |
| Sacubitril Calcium | 1369773-39-6 | Human | Under Development | |
| Sacubitril Sodium | 149115-47-3 (related to the sodium form) | Human | Under Development | |
| Sacubitril Valsartan | 936623-90-4 | Human | Commercial | |
| Sacubitril Valsartan Trisodium Hemipentahydrate | 1426129-50-1 | Human | Under Development | |
| Safinamide | 133865-89-1 | N Nervous System | Human | Commercial |
| Safinamide Mesilate | 202825-46-5 | N Nervous System | Human | Commercial |
| Salbutamol Sulfate | 51022-70-9 | R Respiratory System | Human | Commercial |
| Salcaprozate Sodium | 203787-91-1 | Human | Under Development | |
| Salmeterol Xinafoate | 94749-08-3 | Human | Commercial | |
| Salsalate | 552-94-3 | N Nervous System | Human | Commercial |
| Samidorphan | 852626-89-2 | Human | Under Development | |
| Sapropeterin | 69056-38-8 | A Alimentary Tract and Metabolism | Human | Under Development |
| Sapropterin | 62989-33-7 | A Alimentary Tract and Metabolism | Human | Under Development |
| Savuconazonium Sulfate | 241479-67-4 | Human | Under Development | |
| Saxagliptin | 361442-04-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Saxagliptin H2O | 709031-78-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Saxagliptin Hydrochloride | 709031-78-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Saxagliptin Hydrochloride Dihydrate | 709031-78-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Scopolamine Butylbromide | 149-64-4 | Human | Under Development | |
| Selegiline Base | 14611-52-0 | N Nervous System | Human | Commercial |
| Selegiline Hydrochloride | n.a. | N Nervous System | Human | Commercial |
| Selenious Acid | 7783-00-8 | Human | Commercial | |
| Selexipag | 475086-01-2 | B Blood and Blood Forming Organs | Human | Under Development |
| Selexipag Form l | 475086-01-2 | B Blood and Blood Forming Organs | Human | Under Development |
| Selinexor | 1393477-72-9 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Selpercatinib | 2152628-33-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Selumetinib | 606143-52-6 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Selumetinib Sulfate | 943332-08-9 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Semaglutide | 910463-68-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Semaglutide Acetate | 910463-68-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Serratiopeptidase | 70851-98-8 | Human | Commercial | |
| Sertaconazole | 99592-32-2 | D Dermatologicals | Human | Commercial |
| Sertaconazole Nitrate | 99592-32-2 | D Dermatologicals | Human | Commercial |
| Sertraline | 79617-96-2 | N Nervous System | Human | Commercial |
| Sertraline Hydrochloride | 79559-97-0 | N Nervous System | Human | Commercial |
| Sertraline Hydrochloride Form I | 79559-97-0 | N Nervous System | Human | Commercial |
| Sertraline Hydrochloride Form II | 79559-97-0 | N Nervous System | Human | Commercial |
| Setmelanotide Acetate | 1229022-83-6 | A Alimentary Tract and Metabolism | Human | Under Development |
| Sevelamer | 52757-95-6 | V Various | Human | Commercial |
| Sevelamer Carbonate | 845273-93-0 | V Various | Human | Commercial |
| Sevelamer Hydrochloride | 152751-57-0 | V Various | Human | Commercial |
| Sildenafil Citrate | 171599-83-0 | Human | Commercial | |
| Silodosin | 160970-54-7 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Silver Sulfadiazine | 22199-08-2 | Human | Commercial | |
| Silymarin | 65666-07-1 | V Various | Human | Commercial |
| Simvastatin | 79902-63-9 | C Cardiovascular System | Human | Commercial |
| Siponimod | 1230487-00-9 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Siponimod Fumaric Acid | n.a. | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Sirolimus | 53123-88-9 | D Dermatologicals | Human | Commercial |
| Sitagliptin | 486460-32-6 | A Alimentary Tract and Metabolism | Human | Under Development |
| Sitagliptin Base | 486460-32-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Sitagliptin Hydrochloride | 486460-32-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Sitagliptin Malate | 541015-73-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Sitagliptin Phosphate | 654671-78-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Sitagliptin Phosphate Anhydrous | 654671-78-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Sitagliptin Phosphate H2O | 654671-78-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Sitagliptin Tartrate | 654671-78-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Sivelestat Sodium Tetrahydrat | 202983-57-5 | Human | Commercial | |
| Sn38 | 86639-52-3 | Human | Commercial | |
| Sobrerol | 126-76-7 | R Respiratory System | Human | Commercial |
| Sodium | 7440-23-5 | Human | Commercial | |
| Sodium Ascorbate | 134-03-2 | Human | Commercial | |
| Sodium Cromoglycate | 15826-37-6 | Human | Commercial | |
| Sodium Cromolyn / Cromoglycate | 15826-37-6 | Human | Under Development | |
| Sodium Dehydrocholate | 145-41-5 | Human | Commercial | |
| Sodium Dihydrate | 7558-79-4 | Human | Commercial | |
| Sodium Nitroprusside | 13755-38-9 | C Cardiovascular System | Human | Commercial |
| Sodium Oxybate | 502-85-2 | Human | Commercial | |
| Sodium Phenylbutyrate | 1716-12-7 | M Musculo-Skeletal System | Human | Commercial |
| Sodium Picosulphate | 10040-45-6 | Human | Commercial | |
| Sodium Valproate | 1069-66-5 | Human | Commercial | |
| Sodium Zirconium | 64463-97-6 | Human | Under Development | |
| Sodium Zirconium Cyclosilicate | 1444502-09-3 | Human | Under Development | |
| Sodium Zirconium Cyclosolicate | 1444502-09-3 | Human | Under Development | |
| Sofosbuvir | 1190307-88-0 | J Antiinfectives for Systemic Use | Human | Under Development |
| Sofpironium Bromide | 1628106-94-4 | Human | Under Development | |
| Solifenacin Succinate | 242478-38-2 | Human | Commercial | |
| Solifenacin Succinate Form I | 242478-38-2 | Human | Commercial | |
| Solithromycin | 760981-83-7 | J Antiinfectives for Systemic Use | Human | Under Development |
| Solriamfetol | 178429-62-4 | N Nervous System | Human | Commercial |
| Solriamfetol Hydrochloride | 1784290-99-3 | N Nervous System | Human | Under Development |
| Somatostatin Acetate | 38916-34-6 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Sorafenib Tosylate | 475207-59-1 | Human | Commercial | |
| Sotagliflozin | 1018899-04-1 | A Alimentary Tract and Metabolism | Human | Under Development |
| Sotalol Hydrochloride | 959-24-0 | C Cardiovascular System | Human | Commercial |
| Sotorasib | 2296729-00-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Sparsentan | 254740-64-2 | C Cardiovascular System | Human | Under Development |
| Spironolactone | 52-01-7 | C Cardiovascular System | Human | Commercial |
| Staurosporine | 62996-74-1 | Human | Under Development | |
| Stiripentol | 49763-96-4 | N Nervous System | Human | Commercial |
| Strontium Ranelate | 135459-87-9 | Human | Commercial | |
| Succinylcholine | 306-40-1 | Human | Commercial | |
| Succinylcholine Chloride | 71-27-2 | Human | Commercial | |
| Sucralfate | 54182-58-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Sucroferric Oxyhydroxide | 872577-26-5 | Human | Commercial | |
| Sufentanil Base | 56030-54-7 | N Nervous System | Human | Commercial |
| Sufentanil Citrate | 60561-17-3 | N Nervous System | Human | Commercial |
| Sugammadex | 343306-71-8 | V Various | Human | Commercial |
| Sugammadex Sodium | 343306-79-6 | V Various | Human | Commercial |
| Sulbactam Sodium | 69388-84-7 | Human | Commercial | |
| Sulconazole Nitrate | 61318-91-0 | Human | Commercial | |
| Sulfamethizole | 144-82-1 | B Blood and Blood Forming Organs | Human | Commercial |
| Sulfamethoxazole | 723-46-6 | Human | Commercial | |
| Sulfasalazine | 599-79-1 | A Alimentary Tract and Metabolism | Human | Commercial |
| Sulfonium Cl Vitamin U | n.a. | Human | Commercial | |
| Sulfoxide | 1739-84-0 | Human | Under Development | |
| Sulindac | 38194-50-2 | M Musculo-Skeletal System | Human | Commercial |
| Sulpiride | 15676-16-1 | N Nervous System | Human | Commercial |
| Sumatriptan | 103628-46-2 | N Nervous System | Human | Commercial |
| Sumatriptan Base | 103628-46-2 | N Nervous System | Human | Commercial |
| Sumatriptan Succinate | 103628-48-4 | N Nervous System | Human | Commercial |
| Sunitinib Base | 557795-19-4 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Sunitinib Malate | 341031-54-7 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Suvorexant | 1030377-33-3 | N Nervous System | Human | Commercial |
| Tacrolimus | 104987-11-3 | D Dermatologicals | Human | Commercial |
| Tadalafil | 171596-29-5 | C Cardiovascular System | Human | Commercial |
| Tafamidis | 594839-88-0 | N Nervous System | Human | Commercial |
| Tafamidis Form IV | 594839-88-0 | N Nervous System | Human | Commercial |
| Tafamidis Free Acid | 665848-55-7 | N Nervous System | Human | Under Development |
| Tafamidis Free Base | 665848-55-7 | N Nervous System | Human | Under Development |
| Tafamidis Meglumine | 1073615-71-6 | N Nervous System | Human | Commercial |
| Tafluprost | 209860-87-7 | S Sensory Organs | Human | Commercial |
| Talazoparib Tosylate | 1207456-01-6 | Human | Under Development | |
| Tamoxifene Citrate | 54965-24-1 | Human | Commercial | |
| Tamsulosin | 106133-20-4 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Tamsulosin Hydrochloride | 106463-17-6 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Tapentadol | 175591-23-8 | N Nervous System | Human | Commercial |
| Tapentadol Hydrochloride | 175591-09-0 | N Nervous System | Human | Commercial |
| Tapinarof | 79338-84-4 | D Dermatologicals | Human | Under Development |
| Tapnetadol Phosphate | n.a. | Human | Commercial | |
| Tauroursodeoxycholic Acid | 14605-22-2 | Human | Commercial | |
| Tavaborole | 174671-46-6 | D Dermatologicals | Human | Commercial |
| Tazarotene | 118292-40-3 | D Dermatologicals | Human | Commercial |
| Tazemetostat Hydrobromide | 1403254-99-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Tedizolid | 856866-72-3 | J Antiinfectives for Systemic Use | Human | Under Development |
| Teduglutide | 197922-42-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Teduglutide Acetate | 197922-42-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Tegaserod | 145158-71-0 | A Alimentary Tract and Metabolism | Human | Commercial |
| Tegaserod Maleate | 189188-57-6 | A Alimentary Tract and Metabolism | Human | Under Development |
| Teicoplanin | 61036-62-2 | J Antiinfectives for Systemic Use | Human | Commercial |
| Telmisartan | 144701-48-4 | C Cardiovascular System | Human | Commercial |
| Telotristat | 1033805-28-5 | A Alimentary Tract and Metabolism | Human | Under Development |
| Telotristat Etiprate | 1233484-13-6 | A Alimentary Tract and Metabolism | Human | Under Development |
| Temazepam | 846-50-4 | N Nervous System | Human | Commercial |
| Temozolomide | 85622-93-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Tenapanor | 1234423-95-0 | A Alimentary Tract and Metabolism | Human | Under Development |
| Tenapanor Hydrochloride | 1234423-95-0 | A Alimentary Tract and Metabolism | Human | Under Development |
| Teneligliptin | 760937-92-6 | A Alimentary Tract and Metabolism | Human | Commercial |
| Teneligliptin Hydrobromide H2O | 760937-92-6 | A Alimentary Tract and Metabolism | Human | Under Development |
| Tenofovir Alafenamide | 379270-37-8 | Human | Under Development | |
| Tenofovir Alafenamide Fumarate | 1392275-56-7 | Human | Commercial | |
| Tenofovir Alafenamide Hemifumarate | 1392275-56-7 | Human | Commercial | |
| Tenofovir Alafenamide Maleate | 1798637-55-7 | Human | Under Development | |
| Tenofovir Alafenamide Succinate | n.a. | Human | Under Development | |
| Tenofovir Disoproxil | 147127-20-6 | Human | Under Development | |
| Tenofovir Disoproxil Fumarate | 202138-50-9 | Human | Commercial | |
| Tenofovir TAF | 147127-20-6 | Human | Under Development | |
| Tenofovir TDF | 147127-20-6 | Human | Commercial | |
| Tenoxicam | 59804-37-4 | M Musculo-Skeletal System | Human | Commercial |
| Tepotinib | 1100598-32-0 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Terazosin Hydrochloride | 63074-08-8 | C Cardiovascular System | Human | Commercial |
| Terbinafine | 91161-71-6 | D Dermatologicals | Human | Commercial |
| Terbinafine Hydrochloride | 78628-80-5 | D Dermatologicals | Human | Commercial |
| Terbutaline Sulfate | 23031-32-5 | R Respiratory System | Human | Commercial |
| Terconazole | 67915-31-5 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Teriflunomide | 163451-81-8 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Teriparatide | 52232-67-4 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Teriparatide Acetate | 99294-94-7 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Terlipressin Acetate | 14636-12-5 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Ternidazole | 1077-93-6 | Human | Commercial | |
| Tesetaxel | 333754-36-2 | Human | Under Development | |
| Testosterone | 58-22-0 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Testosterone Base | 58-22-0 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Testosterone Cypionate | 58-20-8 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Testosterone Decanoate | 5721-91-5 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Testosterone Isocarproate | 15262-86-9 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Testosterone Phenylpropionate | 1255-49-8 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Testosterone Propionate | 57-85-2 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Testosterone Undecanoate | 5949-44-0 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Tetrabenazine | 58-46-8 | N Nervous System | Human | Commercial |
| Tetracosactide Acetate | 16960-16-0 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Commercial |
| Tetrahydrozoline | 84-22-0 | Human | Commercial | |
| Tezacaftor | 1152311-62-0 | Human | Under Development | |
| Thalidomide | 50-35-1 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| THC In Ethanol | 1972-08-3 (for THC) | Human | Commercial | |
| THC In Sesame Oil / Dronabinol | 1972-08-3 (for THC) | Human | Commercial | |
| Theophylline | 58-55-9 | C Cardiovascular System | Human | Commercial |
| Thioctic Acid | 62-46-4 | Human | Commercial | |
| Thioridazine Hydrochloride | 130-61-0 | N Nervous System | Human | Commercial |
| Thiotepa | 52-24-4 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Thymoxamine Hydrochloride | 3456-84-8 | Human | Commercial | |
| Tiagabine Hydrochloride | 145821-59-6 | N Nervous System | Human | Under Development |
| Tiapride Hydrochloride | 51012-33-0 | N Nervous System | Human | Commercial |
| Tiaprofenic Acid | 33005-95-7 | Human | Commercial | |
| Tiazotic Acid Morpholinum NaCl | n.a. | Human | Commercial | |
| Tibolone | 5630-53-5 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Ticagrelor | 274693-27-5 | B Blood and Blood Forming Organs | Human | Commercial |
| Ticagrelor Form II | 274693-27-5 | B Blood and Blood Forming Organs | Human | Under Development |
| Ticlopidine Hydrochloride | 53885-35-1 | B Blood and Blood Forming Organs | Human | Commercial |
| Tiemonium Methyl Sulfate | 3735-73-9 | Human | Commercial | |
| Tigecycline | 220620-09-7 | J Antiinfectives for Systemic Use | Human | Commercial |
| Timolol Hemihydrate | 26839-75-8 | C Cardiovascular System | Human | Commercial |
| Timolol Maleate | 26921-17-5 | C Cardiovascular System | Human | Commercial |
| Tioconazole | 65899-73-2 | D Dermatologicals | Human | Commercial |
| Tiopronin | 1953-02-2 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Tiotropium Bromide | 139404-48-1 | Human | Commercial | |
| Tiotropium Bromide Anhydrous | 136310-93-5 | Human | Commercial | |
| Tiotropium Bromide H2O | 136310-93-5 | Human | Commercial | |
| Tipiracil | 183204-74-2 | Human | Under Development | |
| Tirbanibulin | 897016-82-9 | D Dermatologicals | Human | Under Development |
| Tirofiban Base | 144494-65-5 | B Blood and Blood Forming Organs | Human | Commercial |
| Tirofiban Hydrochloride | 150915-41-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Tirofiban Hydrochloride H2O | 150915-41-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Tirzepatide | 2023788-19-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Tivozanib | 475108-18-0 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Tivozanib Hydrochloride H2O | 475108-18-0 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Tizanidine Base | 51322-75-9 | M Musculo-Skeletal System | Human | Commercial |
| Tizanidine Hydrochloride | 64461-82-1 | M Musculo-Skeletal System | Human | Commercial |
| Tobramycin | 32986-56-4 | J Antiinfectives for Systemic Use | Human | Commercial |
| Tocopherol Calcium Succinate | 11006-56-7 | Human | Commercial | |
| Tofacitinib | 477600-75-2 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Tofacitinib Citrate | 540737-29-9 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Tofisopam | 22345-47-7 | N Nervous System | Human | Commercial |
| Tolazoline Hydrochloride | 59-97-2 | C Cardiovascular System | Human | Commercial |
| Tolterodine Tartrate | 124937-52-6 | Human | Commercial | |
| Tolterodine Tartrate Form I | 124937-52-6 | Human | Commercial | |
| Tolvaptan | 150683-30-0 | C Cardiovascular System | Human | Commercial |
| Tolvaptan Amorphous | 150683-30-0 | C Cardiovascular System | Human | Commercial |
| Tolvaptan Crystalline | 150683-30-0 | C Cardiovascular System | Human | Commercial |
| Topiramate | 97240-79-4 | N Nervous System | Human | Commercial |
| Topotecan | 123948-87-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Topotecan Hydrochloride | 119413-54-6 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Torasemide | 56211-40-6 | C Cardiovascular System | Human | Commercial |
| Toremifene Citrate | 89778-27-8 | Human | Commercial | |
| Trabectedin | 114899-77-3 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Tramadol Hydrochloride | 36282-47-0 | N Nervous System | Human | Commercial |
| Trametinib Dimethyl | 871700-17-3 | Human | Under Development | |
| Trandolapril | 87679-37-6 | C Cardiovascular System | Human | Commercial |
| Tranexamic Acid | 1197-18-8 | Human | Commercial | |
| Tranylcypromine Sulfate | 13492-01-8 | N Nervous System | Human | Commercial |
| Travoprost | 157283-68-6 | S Sensory Organs | Human | Commercial |
| Trazodone | 19794-93-5 | N Nervous System | Human | Under Development |
| Trazodone Hydrochloride | 25332-39-2 | N Nervous System | Human | Commercial |
| Trelagliptin | 865759-25-7 | Human | Under Development | |
| Treosulfan | 299-75-2 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Treprostinil | 81846-19-7 | B Blood and Blood Forming Organs | Human | Commercial |
| Treprostinil Diolamine | 81846-19-7 | B Blood and Blood Forming Organs | Human | Commercial |
| Treprostinil Sodium | 701214-79-9 | B Blood and Blood Forming Organs | Human | Commercial |
| Tretinoin | 302-79-4 | D Dermatologicals | Human | Commercial |
| Triamcinolone | 124-94-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Triamcinolone Acetonide | 76-25-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Triamcinolone Acetonide-21-Phosphate Potassium NaCl | 118682-12-3 | A Alimentary Tract and Metabolism | Human | Commercial |
| Triamcinolone Base | 76-25-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Triamcinolone Diacetate | 5611-51-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Triamcinolone Hexacetonide | 5611-51-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Triamterene | 396-01-0 | C Cardiovascular System | Human | Commercial |
| Triazolam | 28911-01-5 | N Nervous System | Human | Commercial |
| Trichlormethiazide | 133-67-5 | C Cardiovascular System | Human | Commercial |
| Trientine Dihydrochloride | 38260-01-4 | A Alimentary Tract and Metabolism | Human | Under Development |
| Trientine Hydrochloride | 38260-01-4 | A Alimentary Tract and Metabolism | Human | Commercial |
| Trifarotene | 895542-09-3 | D Dermatologicals | Human | Under Development |
| Trifluridine | 70-00-8 | S Sensory Organs | Human | Commercial |
| Triheptanoin | 620-67-7 | A Alimentary Tract and Metabolism | Human | Commercial |
| Trilaciclib | 1374743-00-6 | V Various | Human | Under Development |
| Trilaciclib Dihydrochloride | 1608683-38-2 | V Various | Human | Under Development |
| Trimebutine Base | 39133-31-8 | A Alimentary Tract and Metabolism | Human | Commercial |
| Trimebutine Maleate | 34140-59-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Trimeprazine Alimemazine Tartrate | 132-20-7 | Human | Commercial | |
| Trimetazidine Dihdrochloride Form I | 5011-34-7 | Human | Commercial | |
| Trimethobenzamide Hydrochloride | 554-92-7 | R Respiratory System | Human | Commercial |
| Triprolidine Hydrochloride | 6138-79-0 | R Respiratory System | Human | Commercial |
| Triptorelin Acetate | 57773-63-4 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Under Development |
| Trofinetide | 853400-76-7 | N Nervous System | Human | Under Development |
| Tropicamide | 1508-75-4 | S Sensory Organs | Human | Commercial |
| Trospium Chloride | 10405-02-4 | Human | Commercial | |
| Troxerutine | 7085-55-4 | Human | Commercial | |
| Tucatinib | 937263-43-9 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Tulobuterol Base | 41570-61-0 | R Respiratory System | Human | Commercial |
| Tyloxapol | 25301-02-4 | R Respiratory System | Human | Commercial |
| Ubrogepant | 1374248-77-7 | N Nervous System | Human | Under Development |
| Ulipristalacetate | 126784-99-4 | Human | Commercial | |
| Umbralisib | 1532533-67-7 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Umbralisib Tosylate | 949925-00-4 | Human | Under Development | |
| Umeclidinium | 869113-09-7 | Human | Under Development | |
| Umeclidinium Bromide | 869113-09-7 | Human | Under Development | |
| Umifenovir | 131707-25-0 | J Antiinfectives for Systemic Use | Human | Commercial |
| Upadacitinib | 1310726-60-3 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Urapidil | 34661-75-1 | C Cardiovascular System | Human | Commercial |
| Urapidil Base | 34661-75-1 | C Cardiovascular System | Human | Commercial |
| Ursodeoxycholic Acid | 128-13-2 | Human | Commercial | |
| Ursodiol | 128-13-2 | Human | Commercial | |
| UTP Trisodium NaCl | 19817-92-6 | Human | Commercial | |
| Vadadustat | 1000025-07-9 | B Blood and Blood Forming Organs | Human | Under Development |
| Valacyclovir | 124832-27-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Valacyclovir Hydrochloride | 124832-27-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Valacyclovir Hydrochloride Anhydrous | 124832-27-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Valacyclovir Hydrochloride H2O | 124832-27-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Valbenazine | 1025504-45-3 | N Nervous System | Human | Under Development |
| Valbenazine Tosylate | 1025504-45-3 | N Nervous System | Human | Under Development |
| Valgancyclovir | 175865-59-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Valgancyclovir Hydrochloride | 175865-59-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Valgancyclovir Hydrochloride Amorphous | 175865-59-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Valgancyclovir Hydrochloride Crystalline | 175865-59-5 | J Antiinfectives for Systemic Use | Human | Commercial |
| Valproate Semisodium | 76584-70-8 | Human | Commercial | |
| Valproic Acid | 99-66-1 | Human | Commercial | |
| Valrubicin | 56124-62-0 | L Antineoplastic and Immodulating Agents | Human | Commercial |
| Valsartan | 137862-53-4 | C Cardiovascular System | Human | Commercial |
| Valsartan Disodium NaCl | 137862-53-4 | C Cardiovascular System | Human | Under Development |
| Valsartan Sodium | 137862-53-4 | C Cardiovascular System | Human | Commercial |
| Vamorolone | 13209-41-1 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human | Under Development |
| Vancomycin Hydrochloride | 1404-93-9 | Human | Commercial | |
| Vardenafil Hydrochloride | 224785-91-5 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Varenicline | 249296-44-4 | N Nervous System | Human | Under Development |
| Varenicline L-Tartrate | 375815-87-5 | N Nervous System | Human | Commercial |
| Varenicline Tartrate | 375815-87-5 | N Nervous System | Human | Commercial |
| Vasopressin Acetate | 113-79-1 | Human | Commercial | |
| Vazegepant Biohaven | n.a. | Human | Under Development | |
| Vecuronium Bromide | 50700-72-6 | M Musculo-Skeletal System | Human | Commercial |
| Vecuronium Hydrobromide | 50700-72-6 | M Musculo-Skeletal System | Human | Under Development |
| Velpatasvir | 1377049-84-7 | Human | Under Development | |
| Vemurafenib | 918504-65-1 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Venetoclax | 1257044-40-8 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Venglustat | 1401090-53-6 | Human | Under Development | |
| Venlafaxine | 93413-69-5 | N Nervous System | Human | Commercial |
| Venlafaxine Hydrochloride | 99300-78-4 | N Nervous System | Human | Commercial |
| Venlafaxine Hydrochloride Form B | 99300-78-4 | N Nervous System | Human | Commercial |
| Venlafaxine Hydrochloride Form C | 99300-78-4 | N Nervous System | Human | Commercial |
| Verapamil | 52-53-9 | C Cardiovascular System | Human | Commercial |
| Verapamil Hydrochloride | 152-11-4 | C Cardiovascular System | Human | Commercial |
| Vericiguat | 1350653-20-1 | C Cardiovascular System | Human | Under Development |
| Vibegron | 1190389-15-1 | G Genito Urinary System and Sex Hormones | Human | Commercial |
| Vigabatrin | 68506-86-5 | N Nervous System | Human | Commercial |
| Vilanterol | 503068-34-6 | Human | Under Development | |
| Vilanterol Trifenatate | 503070-58-4 | Human | Under Development | |
| Vilazidone Hydrochloride | 163521-12-8 | N Nervous System | Human | Commercial |
| Vilazodone | 163521-12-8 | N Nervous System | Human | Commercial |
| Vilazodone Hydrochloride | 163521-08-2 | N Nervous System | Human | Commercial |
| Vildagliptin | 274901-16-5 | A Alimentary Tract and Metabolism | Human | Commercial |
| Viloxazine | 46817-91-8 | N Nervous System | Human | Under Development |
| Viloxazine Hydrochloride | 35604-67-2 | N Nervous System | Human | Commercial |
| Vinorelbine Tartrate | 125317-39-7 | Human | Commercial | |
| Vismodegib | 879085-55-9 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Vitamin B2-5 Phosphate Sodium | 130-40-5 | Human | Commercial | |
| Vitamin E Derivative | n.a. | Human | Commercial | |
| Vitamin K | 84-80-0 | Human | Commercial | |
| Vitamin K2 - Mk4 | 863-61-6 | Human | Commercial | |
| Vitamin K2 - Mk7 | 2124-57-4 | Human | Commercial | |
| Voclosporine | 515814-01-4 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Vonoprazan | 881681-00-1 | A Alimentary Tract and Metabolism | Human | Under Development |
| Vonoprazan Fumarate | 1260141-27-2 | A Alimentary Tract and Metabolism | Human | Under Development |
| Voriconazole | 137234-62-9 | J Antiinfectives for Systemic Use | Human | Commercial |
| Vortioxetine | 508233-74-7 | N Nervous System | Human | Commercial |
| Vortioxetine Hydrobromide | 960203-27-4 | N Nervous System | Human | Commercial |
| Voxelotor | 1446321-46-5 | B Blood and Blood Forming Organs | Human | Under Development |
| Warfarin Sodium | 129-06-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Warfarin Sodium Amorphous | 129-06-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Warfarin Sodium Clathrate | 129-06-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Warfarin Sodium NaCl Amorphous | 129-06-6 | B Blood and Blood Forming Organs | Human | Under Development |
| Warfarin Sodium NaCl Clathrate | 129-06-6 | B Blood and Blood Forming Organs | Human | Commercial |
| Xylometazoline Hydrochloride | 1218-35-5 | R Respiratory System | Human | Commercial |
| Zafirlukast | 107753-78-6 | R Respiratory System | Human | Commercial |
| Zaleplon | 151319-34-5 | N Nervous System | Human | Commercial |
| Zanubrutinib | 1691249-45-2 | L Antineoplastic and Immodulating Agents | Human | Under Development |
| Zavegepant | 1337918-83-8 | N Nervous System | Human | Under Development |
| Ziconotide Acetate | 107452-89-1 | N Nervous System | Human | Commercial |
| Zileuton | 111406-87-2 | Human | Commercial | |
| Zinc L-Carnosine Complex | 107667-60-7 | Human | Commercial | |
| Ziprasidone Dihydrochloride | 146939-27-7 | N Nervous System | Human | Commercial |
| Ziprasidone Hydrochloride | 146939-27-7 | N Nervous System | Human | Commercial |
| Ziprasidone Hydrochloride Anhydrous | 146939-27-7 | N Nervous System | Human | Commercial |
| Ziprasidone Hydrochloride H2O | 146939-27-7 | N Nervous System | Human | Commercial |
| Ziprasidone Mesilate | 853936-43-5 | N Nervous System | Human | Commercial |
| Ziprasidone Mesilate Trihydrate | 853936-43-5 | N Nervous System | Human | Commercial |
| Zoledronic Acid | 118072-93-8 | Human | Commercial | |
| Zoledronic Acid Form I | 118072-93-8 | Human | Commercial | |
| Zolmitriptan | 139264-17-8 | N Nervous System | Human | Commercial |
| Zolpidem Tartrate | 99294-93-6 | Human | Commercial | |
| Zonisamide | 68291-97-4 | N Nervous System | Human | Commercial |
| Zopiclone | 43200-80-2 | N Nervous System | Human | Commercial |
| Zuranolone | 1632051-40-1 | N Nervous System | Human | Under Development |
| 2-Aminoheptane Sulfate | n.a. | R Respiratory System | Human, Vet | Commercial |
| Afoxolaner | 1093861-60-9 | Human, Vet | Commercial | |
| Albendazole | 54965-21-8 | P Antiparasitic Products, Insecticides and Repellents | Human, Vet | Commercial |
| Altrenogest | 850-52-2 | Human, Vet | Commercial | |
| Aminosidine | 7542-37-2 | A Alimentary Tract and Metabolism | Human, Vet | Commercial |
| Avermectin | 71751-41-2 | D Dermatologicals | Human, Vet | Commercial |
| Carprofen | 53716-49-7 | M Musculo-Skeletal System | Human, Vet | Commercial |
| Clenbuterol Hydrochloride | 21898-19-1 | R Respiratory System | Human, Vet | Commercial |
| Fenbendazole | 43210-67-9 | P Antiparasitic Products, Insecticides and Repellents | Human, Vet | Commercial |
| Flumequine | 42835-25-6 | J Antiinfectives for Systemic Use | Human, Vet | Commercial |
| Furazidin | 67-20-9 | J Antiinfectives for Systemic Use | Human, Vet | Commercial |
| Furazidin Sodium | 57407-27-3 | J Antiinfectives for Systemic Use | Human, Vet | Commercial |
| Itraconazole | 84625-61-6 | J Antiinfectives for Systemic Use | Human, Vet | Commercial |
| Ivermectin | 70288-86-7 | D Dermatologicals | Human, Vet | Commercial |
| Levamisole | 14769-73-4 | L Antineoplastic and Immodulating Agents | Human, Vet | Under Development |
| Lotilaner | 1369852-71-0 | S Sensory Organs | Human, Vet | Under Development |
| Niclosamide Anhydrous | 50-65-7 | P Antiparasitic Products, Insecticides and Repellents | Human, Vet | Commercial |
| Niclosamide Ethanolamine | 1420-04-8 | P Antiparasitic Products, Insecticides and Repellents | Human, Vet | Commercial |
| Nifuratel | 4936-47-4 | G Genito Urinary System and Sex Hormones | Human, Vet | Commercial |
| Nifuroxazide | 965-52-6 | A Alimentary Tract and Metabolism | Human, Vet | Commercial |
| Praziquantel | 55268-74-1 | P Antiparasitic Products, Insecticides and Repellents | Human, Vet | Commercial |
| Propentofylline | 55242-55-2 | N Nervous System | Human, Vet | Commercial |
| Sulfadmethoxine Sodium | 1037-50-9 | J Antiinfectives for Systemic Use | Human, Vet | Commercial |
| Sulfapyridlne | 144-83-2 | J Antiinfectives for Systemic Use | Human, Vet | Commercial |
| Sulfathiazole | 72-14-0 | D Dermatologicals | Human, Vet | Commercial |
| Tafenoquine | 106635-80-7 | P Antiparasitic Products, Insecticides and Repellents | Human, Vet | Commercial |
| Triclabendazole | 68786-66-3 | P Antiparasitic Products, Insecticides and Repellents | Human, Vet | Commercial |
| Trilostane | 13647-35-3 | H Systemic Hormonal Preperations, excl. Sex Hormones and Insulins | Human, Vet | Commercial |
| Tulathromycin | 217500-96-4 | J Antiinfectives for Systemic Use | Human, Vet | Commercial |
| Amitraz | 33089-61-1 | Vet | Commercial | |
| Atipamezole Hydrochloride | 104075-48-1 | Vet | Commercial | |
| Azaperone | 1649-18-9 | Vet | Commercial | |
| Buparvaquone | 88426-33-9 | Vet | Commercial | |
| Butaphosphan | 17316-67-5 | Vet | Commercial | |
| Cefovecin | 234096-34-5 | Vet | Under Development | |
| Cephapirin Benzathine | 97468-37-6 | Vet | Commercial | |
| Cephapirin Sodium | 24356-60-3 | Vet | Commercial | |
| Cimicoxib | 265114-23-6 | Vet | Commercial | |
| Clorsulon | 60200-06-8 | Vet | Commercial | |
| Closantel | 57808-65-8 | Vet | Commercial | |
| Closantel Sodium Dihydrate | 61438-64-0 | Vet | Commercial | |
| Deracoxib | 169590-41-4 | Vet | Commercial | |
| Detomidine Hydrochloride | 90038-01-0 | Vet | Commercial | |
| Di-Cloprostenol Sodium | n.a. | Vet | Commercial | |
| Diminazene Aceturate | 908-54-3 | Vet | Commercial | |
| Epsiprantel | 98123-83-2 | Vet | Commercial | |
| Fipronil | 120068-37-3 | Vet | Commercial | |
| Firocoxib | 189954-96-9 | Vet | Commercial | |
| Florfenicol | 73231-34-2 | Vet | Commercial | |
| Fluazuron | 86811-58-7 | Vet | Under Development | |
| Flumethrin | 69770-45-2 | Vet | Under Development | |
| Flunixin Meglumine | 42461-84-7 | Vet | Commercial | |
| Fluralaner | 864731-61-3 | Vet | Commercial | |
| Gamithromycin | 145435-72-9 | Vet | Under Development | |
| Grapiprant | 415903-37-6 | Vet | Under Development | |
| Homidium Chloride | 20256-78-2 | Vet | Commercial | |
| Imepitoin | 188116-07-6 | Vet | Under Development | |
| Imidocarb Dipropionate | 27885-92-3 | Vet | Commercial | |
| Lufenuron | 103055-07-8 | Vet | Commercial | |
| Lumefantrine | 82186-77-4 | Vet | Commercial | |
| Marbofloxacin | 115550-35-1 | vet | Commercial | |
| Maropitant | 147116-67-4 | vet | Commercial | |
| Maropitant Citrate | 359875-09-5 | vet | Commercial | |
| Maropitant Citrate H2O | n.a. | vet | Commercial | |
| Mavacoxib | 170569-88-7 | Vet | Commercial | |
| Medetomidine Hydrochloride | 86347-15-1 | Vet | Commercial | |
| Melengestrol Acetate | 2919-66-6 | Vet | Commercial | |
| Milbemycin Oxime | 129496-10-2 | Vet | Commercial | |
| Morantel Tartrate | 26155-31-7 | Vet | Commercial | |
| Nitenpyram | 150824-47-8 | Vet | Commercial | |
| Nitrofurazone | 59-87-0 | Vet | Commercial | |
| Nitroscanate | 19881-18-6 | Vet | Under Development | |
| Nitroxynil | 1689-89-0 | Vet | Commercial | |
| Oclatinib Maleate | 1208319-26-9 | Vet | Commercial | |
| Osaterone Acetate | 302-97-6 | Vet | Commercial | |
| Oxantel Pamoate | 68813-55-8 | Vet | Commercial | |
| Oxfendazole | 53716-50-0 | Vet | Under Development | |
| Oxibendazole | 20559-55-1 | Vet | Commercial | |
| Parvaquone | 4042-30-2 | Vet | Commercial | |
| Pimobendan | 74150-27-9 | Vet | Commercial | |
| Ponazuril | 69004-04-2 | Vet | Commercial | |
| Pyrantel Embonate | 22204-24-6 | Vet | Commercial | |
| Pyrantel Pamoate | 22204-24-6 | Vet | Commercial | |
| Pyrantel Pamoate Isomorphic | n.a. | Vet | Commercial | |
| Pyrantel Tartrate Zeolex Isomorphic | n.a. | Vet | Commercial | |
| Ractopamine Hydrochloride | 90274-24-1 | Vet | Commercial | |
| Reobenacoxib | 220991-32-2 | Vet | Commercial | |
| Ricobendazole | 54029-12-8 | Vet | Commercial | |
| Robenidine Hydrochloride | 25875-50-7 | Vet | Commercial | |
| Romifidine | 65896-16-4 | Vet | Under Development | |
| Ronidazole | 7681-76-7 | Vet | Commercial | |
| Tetramisole | 5036-02-2 | Vet | Under Development | |
| Tildipirosin | 328898-40-4 | Vet | Under Development | |
| Toceranib | 356068-94-5 | Vet | Under Development | |
| Toldimfos Sodium | 5787-63-3 | Vet | Commercial | |
| Toltrazuril | 69004-03-1 | Vet | Commercial | |
| Trenbolone Acetate | 10161-34-9 | Vet | Commercial | |
| Valnemuline Hydrochloride | 133868-46-9 | Vet | Commercial | |
| Xylazine Hydrochloride | 23076-35-9 | Vet | Commercial | |
| Zilpaterol | 119520-05-7 | Vet | Under Development | |
| Zilpaterol Hydrochloride | 119520-06-8 | Vet | Commercial | |
| Zolazepam | 22457-31-4 | vet | Under Development |
We also offer a portfolio of Intermediate, Extracts, and Excipients. Please contact us by filling out the contact form on this webpage, or directly send an email to info-api@tiefenbacher.com.
Disclaimer: for more details, please go here
TIEFENBACHER API + INGREDIENTS: your partner for complex APIs with exceptional services
API Synthesis: From route scouting to lab scale development to commercial supply
Custom synthesis of intermediates & APIs – with greater control and a carefully selected CDMO that fits your project best.
We, at TIEFENBACHER API + INGREDIENTS make it right the first time, from grams to tons. A structured and methodical approach enables us to identify your individual requirements and implement them precisely. Our strong network of 200+ manufacturing partners and our sophisticated market intelligence allow us to choose the best fit. We work closely with you and the selected CDMO during all the planning and execution phases to assure we meet your and the product’s requirements.
Harness the true potential of APIs to fuel innovation and stay ahead of the competition
Whatever challenge you face throughout the sourcing process or the synthesis of APIs for your pharmaceuticals, we can work together to develop a custom solution to meet your specific requirements – regardless of your project size or complexity.
For more information about our API synthesis service, please contact us at any stage of your inquiry and process by filling out the contact form below on this webpage or send an email directly to s.thiel@tiefenbacher.com.
Humans, animals, and the environment – our health is connected
Veterinary APIs that improve the health of companion and farm animals
TIEFENBACHER API + INGREDIENTS offers a wide variety of products for companion and farm animals with the highest demand concerning quality and reliability.
We believe that when animals are healthy, humans are healthier too – therefore we are committed to improve both animal and human health. With roots in Europe, and more than 60 years of pharmaceutical expertise, our animal health division brings solutions to the market that benefit the well-being and productivity of our animals. Our sourcing capability is built on long standing partnerships with GMP-manufacturers and an ever expanding global network of suppliers in Europe + Asia – with their support we always aim to provide a reliable solution – dedicated to your specific requirements and distributed following GDP (Good Distribution Practices).
Animal Health: Market leading capabilities for a growth market
We care for farm and companion animals and welcome all types of business enquiries regarding veterinary products. TIEFENBACHER API + INGREDIENTS goes beyond API-distribution and has the flexibility to deliver the product you need to improve the well-being of animals and their humans.
For more information on veterinary APIs for livestock and companion animals, please contact us at any stage of your inquiry – by filling out the contact form below on this webpage, or send an e-mail directly to olaf.hoffmann@tiefenbacher.com.
Quality and maximum safety throughout the entire API-Distribution
High-quality APIs for human & animal health – in all 14 ATC therapy groups
For human & animal health: Our GMP and GDP certificates attest to our high level of quality and safety along the entire value chain – in addition, we have the permission to handle narcotics according to § 3 BtmG.
High-quality is essential in the production of safe and reliable pharmaceuticals. You need purity, consistency, transparency, and quality to guarantee the same in your final products. TIEFENBACHER API + INGREDIENTS is the preferred distributor in the pharmaceutical, veterinary, and healthcare industries. We offer a comprehensive range of raw materials (human + veterinary) with the highest demand concerning quality and security in all fourteen main ATC-groups with an EU Drug Master File. All our products (APIs, Ingredients, Excipients) are manufactured at trusted GMP facilities in Europe and Asia and distributed following Good Distribution Practices (GDP). We reduce supply chain vulnerability by having multiple sourcing options for safe, reliably pharmaceuticals.
In short: Tiefenbacher API + Ingredients is the single source for everything you need. We are delivering the right API-product in a timely, efficient, and secure manner.
[A] Alimentary tract and metabolism
[B] Blood and blood forming organs
[C] Cardiovascular system
[D] Dermatological
[G] Genito-urinary system and sex hormones
[H] Systemic hormonal preparations,excluding sex hormones and insulins
[J] Anti-infective for systemic use
[L] Antineoplastic and immunomodulating agents
[M] Musculo-skeletal system
[N] Nervous system
[P] Antiparasitic products, insecticides and repellents
[R] Respiratory system
[S] Sensory organs
[V] Various
API-Distribution
TIEFENBACHER API + INGREDIENTS offer more than 600+ APIs (Human + Veterinary) to secure the pharmaceutical industry with high-quality solutions along the entire API-value chain. Our products are manufactures according to Good Manufacturing Practice (GMP) and distributed following Good Distribution Practice (GDP). Please contact us for high-quality API-Distribution by filling out the contact form below and clicking “Send message”, or directly send an email to info-api@tiefenbacher.com. TIEFENBACHER API + INGREDIENTS will follow up with you personally as soon as possible.
TIEFENBACHER API + INGREDIENTS GMBH & CO. KG
Van-der-Smissen-Strasse 1-2
22767 Hamburg
Germany
Phone: +49 40 – 36 09 18 – 0
Fax: +49 40 – 36 09 18 – 222
Mail: info-api@tiefenbacher.com
